<?xml version="1.0" encoding="UTF-8"?>

<ODM xmlns="http://www.ich.org/ns/odm/v1.3" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:nciodm="http://ncicb.nci.nih.gov/xml/odm/EVS/CDISC"xmlns:ich="http://ncicb.nci.nih.gov/xml/odm/EVS/ICH"  FileType="Snapshot" FileOID="ICH_CT.M11.2025-08-04" Granularity="Metadata" CreationDateTime="2025-09-23T22:46:54" AsOfDateTime="2025-08-04T00:00:00" ODMVersion="1.3.2" Originator="CDISC XML Technologies Team (Terminology2ODM converter)" SourceSystem="NCI Thesaurus" SourceSystemVersion="2025-08-04" nciodm:Context="Submission" nciodm:ControlledTerminologyVersion="1.2.0">
    <Study OID="ICH_CT.M11.2025-08-04">
        <GlobalVariables>
            <StudyName>ICH M11 Controlled Terminology</StudyName>
            <StudyDescription>ICH M11 Controlled Terminology, 2025-08-04</StudyDescription>
            <ProtocolName>ICH M11 Controlled Terminology</ProtocolName>
        </GlobalVariables>
        <MetaDataVersion OID="ICH_CT_MetaDataVersion.M11.2025-08-04" Name="ICH M11 Controlled Terminology" Description="ICH M11 Controlled Terminology, 2025-08-04">
            <CodeList OID="CL.C217274.Amendment Details Statement Response Terminology" Name="Amendment Details Statement Response Terminology" DataType="text" nciodm:ExtCodeID="C217274">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the amendment details statement responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Not applicable. This protocol has not been amended." nciodm:ExtCodeID="C218485">
                    <ich:ICHDefinition>Not applicable. This protocol has not been amended.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Not Applicable, Protocol Not Amended</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="This is the first protocol amendment." nciodm:ExtCodeID="C218486">
                    <ich:ICHDefinition>This is the first protocol amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>First Protocol Amendment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="This protocol has been amended previously. Details of prior amendments are presented in Section 12.3 Prior Protocol Amendments." nciodm:ExtCodeID="C218487">
                    <ich:ICHDefinition>This protocol has been amended previously. Details of prior amendments are presented in Section 12.3 Prior Protocol Amendments.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Previously Amended, Details Presented</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="This protocol has been amended previously. The Protocol Amendment Summary of Changes for the current amendment is located directly before the Table of Contents. Prior amendment(s) to this protocol are listed in the table below, beginning with the most recent." nciodm:ExtCodeID="C218488">
                    <ich:ICHDefinition>This protocol has been amended previously. The Protocol Amendment Summary of Changes for the current amendment is located directly before the Table of Contents. Prior amendment(s) to this protocol are listed in the table below, beginning with the most recent.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Previously Amended See Summary of Changes Before the Table of Contents</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Amendment Details Statement Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Amendment Details Statement Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Amendment Details Statement Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217275.Amendment Scope Enrollment Description Response Terminology" Name="Amendment Scope Enrollment Description Response Terminology" DataType="text" nciodm:ExtCodeID="C217275">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the amendment scope enrollment description responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="By Cohort" nciodm:ExtCodeID="C218489">
                    <ich:ICHDefinition>Covering or affecting a cohort of individuals.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>By Cohort</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Globally" nciodm:ExtCodeID="C68846">
                    <ich:ICHDefinition>Covering or affecting the whole of a system.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Global</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Locally" nciodm:ExtCodeID="C41065">
                    <ich:ICHDefinition>Covering or affecting a portion of the system.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Locally</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Amendment Scope Enrollment Description Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Amendment Scope Enrollment Description Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Amendment Scope Enrollment Description Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217047.Amendment Scope Response Terminology" Name="Amendment Scope Response Terminology" DataType="text" nciodm:ExtCodeID="C217047">
                <Description>
                    <TranslatedText xml:lang="en">Terminology associated with the amendment scope value set codelist of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Global" nciodm:ExtCodeID="C68846">
                    <ich:ICHDefinition>Covering or affecting the whole of a system.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Global</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Not Global" nciodm:ExtCodeID="C217026">
                    <ich:ICHDefinition>Covering or affecting a portion of the system.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Not Global</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Amendment Scope Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Amendment Scope Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Amendment Scope Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217279.Control Type Response Terminology" Name="Control Type Response Terminology" DataType="text" nciodm:ExtCodeID="C217279">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the control type responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Active Comparator" nciodm:ExtCodeID="C49649">
                    <ich:ICHSynonym>Active Control</ich:ICHSynonym>
                    <ich:ICHDefinition>A type of control, which has a demonstrated effect, administered as a comparator to participants in a clinical trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Active Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Different Dose or Regimen" nciodm:ExtCodeID="C218505">
                    <ich:ICHDefinition>A type of control that comprises a different dose or dosage regimen in comparison to the investigational intervention dose or dosage regimen.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Different Dose or Regimen Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Dose Response" nciodm:ExtCodeID="C120841">
                    <ich:ICHDefinition>A type of control using different doses or regimens of the same treatment across the treatment arms.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Dose Response Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="External" nciodm:ExtCodeID="C218506">
                    <ich:ICHDefinition>The use of external control data as a control arm for those studies where ethical concerns and/or underserved disease indications may make it difficult to enroll participants.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>External Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="No Control" nciodm:ExtCodeID="C28280">
                    <ich:ICHDefinition>A clinical study that lacks a comparison (i.e., a control) group.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Uncontrolled Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Placebo" nciodm:ExtCodeID="C49648">
                    <ich:ICHSynonym>Placebo</ich:ICHSynonym>
                    <ich:ICHSynonym>Placebo Control</ich:ICHSynonym>
                    <ich:ICHDefinition>An inactive, identical-appearing drug or treatment that does not contain the test product.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Placebo Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sham Procedure" nciodm:ExtCodeID="C184727">
                    <ich:ICHDefinition>A type of negative control in which a procedure is performed that mimics the procedure under study but does not include investigational processes or components.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Sham Control</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Control Type Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Control Type Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Control Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217342.ICH M11 Section 1 Terminology" Name="ICH M11 Section 1 Terminology" DataType="text" nciodm:ExtCodeID="C217342">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 1 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Adaptive Trial Design Indicator" nciodm:ExtCodeID="C218706">
                    <ich:ICHDefinition>An indication as to whether the clinical trial uses an adaptive trial design.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Adaptive Trial Design Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Additional Description of Duration" nciodm:ExtCodeID="C218838">
                    <ich:ICHDefinition>A narrative providing additional details about the duration of an participant&apos;s use of a trial intervention or their planned participation time in the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Additional Description of Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Alternate Description of Planned Duration of Trial Intervention" nciodm:ExtCodeID="C218714">
                    <ich:ICHDefinition>An alternative textual narrative for the planned duration of trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Alternate Description of Planned Duration of Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Alternate Description of Planned Duration of Trial Participation" nciodm:ExtCodeID="C218717">
                    <ich:ICHDefinition>An alternative narrative for the planned duration of trial participation.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Alternate Description of Planned Duration of Trial Participation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Blinded Roles" nciodm:ExtCodeID="C218709">
                    <ich:ICHSynonym>Blinding roles</ich:ICHSynonym>
                    <ich:ICHDefinition>An identifying designation assigned to a blinded individual within a clinical trial that corresponds with their function.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Blinding Role</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Control Type" nciodm:ExtCodeID="C49647">
                    <ich:ICHDefinition>A characterisation or classification of the comparator against which the study intervention is evaluated.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Control Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Drug/Device Combination Product Indicator" nciodm:ExtCodeID="C218708">
                    <ich:ICHDefinition>An indication as to whether the clinical trial is testing a drug-device combination product.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Drug/Device Combination Product Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Independent Committees" nciodm:ExtCodeID="C218718">
                    <ich:ICHDefinition>An independent group of experts that has oversight over, and conducts periodic review of, specific trial activities.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Independent Oversight Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="INN" nciodm:ExtCodeID="C142585">
                    <ich:ICHSynonym>International Nonproprietary Name</ich:ICHSynonym>
                    <ich:ICHDefinition>A unique name that is globally recognised and public property, which identifies pharmaceutical substances or active pharmaceutical ingredients.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>International Nonproprietary Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Intervention Assignment Method" nciodm:ExtCodeID="C218475">
                    <ich:ICHDefinition>The technique used to assign trial participants to a trial intervention or trial arm.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Intervention Assignment Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Intervention Model" nciodm:ExtCodeID="C98746">
                    <ich:ICHSynonym>Intervention Model</ich:ICHSynonym>
                    <ich:ICHDefinition>The overall design configuration for assigning intervention to participants.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Intervention Model</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Master Protocol Indicator" nciodm:ExtCodeID="C218707">
                    <ich:ICHDefinition>An indication as to whether the protocol is a master protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Master Protocol Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Maximum Age" nciodm:ExtCodeID="C49694">
                    <ich:ICHDefinition>The anticipated maximum age of the participants to be entered in a clinical trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Planned Maximum Age of Subjects</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Minimum Age" nciodm:ExtCodeID="C49693">
                    <ich:ICHDefinition>The anticipated minimum age of the participants to be entered in a clinical trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Planned Minimum Age of Subjects</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Nonproprietary Name(s)" nciodm:ExtCodeID="C97054">
                    <ich:ICHSynonym>Generic Name</ich:ICHSynonym>
                    <ich:ICHSynonym>Public Name</ich:ICHSynonym>
                    <ich:ICHDefinition>Drug name that is not protected by a trademark, usually descriptive of its chemical structure, and sometimes a public name. (ICH E2B)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Generic Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Number of Arms" nciodm:ExtCodeID="C98771">
                    <ich:ICHDefinition>The planned number of intervention groups.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Planned Number of Arms</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Number of Participants" nciodm:ExtCodeID="C49692">
                    <ich:ICHDefinition>The planned number of participants to be entered in a clinical trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Planned Subject Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other Committees" nciodm:ExtCodeID="C218719">
                    <ich:ICHDefinition>A committee that is different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Population Diagnosis or Condition" nciodm:ExtCodeID="C112038">
                    <ich:ICHDefinition>A description of the condition, disease or disorder that the clinical trial is intended to investigate or address.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Indication</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Population Type" nciodm:ExtCodeID="C218703">
                    <ich:ICHDefinition>A characterisation or classification of the trial population.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Population Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Primary and Secondary Objectives and Estimands" nciodm:ExtCodeID="C218839">
                    <ich:ICHDefinition>A descriptive summary of the primary and secondary objectives and their associated estimands related to the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Primary and Secondary Objectives and Estimands Summary</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Randomly Assigned to Trial Intervention/Enrolled" nciodm:ExtCodeID="C218711">
                    <ich:ICHDefinition>The target or maximum number of participants who have been randomly assigned to the trial intervention or enrolled in the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Number of Participants Randomly Assigned to Trial Intervention or Enrolled</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Schedule of Activities" nciodm:ExtCodeID="C132349">
                    <ich:ICHDefinition>A standardised representation of planned clinical trial activities including interventions (e.g., administering drug, surgery) and study administrative activities (e.g., obtaining informed consent, distributing clinical trial material and diaries, randomisation) as well as assessments.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Schedule of Activities</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Schema Notes" nciodm:ExtCodeID="C218720">
                    <ich:ICHDefinition>A brief written record describing the trial schematic.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Schematic Note</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Site Distribution" nciodm:ExtCodeID="C218704">
                    <ich:ICHDefinition>An indication as to whether the occurrence applies to a single or multiple trial sites.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Site Distribution Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Site Geographic Scope" nciodm:ExtCodeID="C218705">
                    <ich:ICHDefinition>An indication as to whether the trial is taking place in one or more countries.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Site Geographic Scope Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Target/Maximum" nciodm:ExtCodeID="C218710">
                    <ich:ICHDefinition>A characterisation or classification of the trial participant numbers as to whether the numbers reflect a target or maximum.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Participation Number Target or Maximum Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Total Planned Duration of Trial Intervention Unit of Time" nciodm:ExtCodeID="C218713">
                    <ich:ICHDefinition>The unit of time associated with the numeric value for the planned duration of trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Planned Duration of Trial Intervention Unit of Time</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Total Planned Duration of Trial Intervention" nciodm:ExtCodeID="C218712">
                    <ich:ICHDefinition>The numeric value for the planned duration of trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Planned Duration of Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Total Planned Duration of Trial Participation Unit of Time" nciodm:ExtCodeID="C218716">
                    <ich:ICHDefinition>The unit of time associated with the numeric value for the planned duration of trial participation.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Planned Duration of Trial Participation Unit of Time</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Total Planned Duration of Trial Participation" nciodm:ExtCodeID="C218715">
                    <ich:ICHDefinition>The numeric value for the planned duration of trial participation.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Planned Duration of Trial Participation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Blind Schema" nciodm:ExtCodeID="C49658">
                    <ich:ICHDefinition>The type of experimental design used to describe the level of awareness of the trial participants and/ or personnel as it relates to the respective intervention(s) or assessments being observed, received or administered.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Blinding Schema</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Schema" nciodm:ExtCodeID="C93682">
                    <ich:ICHDefinition>A diagram that outlines the decision points (e.g. randomisation, response evaluation) that define the different paths a participant could take through the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Schematic</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Units of Age" nciodm:ExtCodeID="C50400">
                    <ich:ICHDefinition>Those units of time that are routinely used to express the age of a person.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Age Unit</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 1 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 1 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 1 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217351.ICH M11 Section 10 Terminology" Name="ICH M11 Section 10 Terminology" DataType="text" nciodm:ExtCodeID="C217351">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 10 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Analyses of Demographics and Other Baseline Variables" nciodm:ExtCodeID="C218802">
                    <ich:ICHDefinition>A description of analyses relevant to variables at baseline, for example demographics, related to the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Trial Baseline Variable Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Analysis Associated with Exploratory Objectives(s)" nciodm:ExtCodeID="C218807">
                    <ich:ICHDefinition>A description of the statistical model, hypothesis, and methods of analyses for each exploratory objective within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Exploratory Objective Statistical Analysis Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Analysis Sets" nciodm:ExtCodeID="C218801">
                    <ich:ICHDefinition>A description of the set of participants whose data are to be included in the analyses.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of the Participants Included in Data Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="General Considerations" nciodm:ExtCodeID="C164387">
                    <ich:ICHDefinition>Careful thought or deliberation related to the planned conduct of statistical analyses within the context of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>General Statistical Consideration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Handling of Data in Relation to Primary Estimand(s)" nciodm:ExtCodeID="C218803">
                    <ich:ICHDefinition>A description of how data will be handled for the statistical analysis in line with the primary estimand.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Handling of Data in Relation to Primary Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Handling of Data in Relation to Secondary Estimand(s)" nciodm:ExtCodeID="C218805">
                    <ich:ICHDefinition>A description of how data will be handled for the statistical analysis in line with the secondary estimand.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Handling of Data in Relation to Secondary Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Handling of Missing Data in Relation to Primary Estimand(s)" nciodm:ExtCodeID="C218804">
                    <ich:ICHDefinition>A description of how missing data associated with the primary estimand will be handled, including the rationale for the approach.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Handling of Missing Data in Relation to Primary Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Handling of Missing Data in Relation to Secondary Estimand(s)" nciodm:ExtCodeID="C218806">
                    <ich:ICHDefinition>A description of how missing data associated with the secondary estimand will be handled, including the rationale for the approach.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Handling of Missing Data in Relation to Secondary Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Interim Analyses" nciodm:ExtCodeID="C142582">
                    <ich:ICHDefinition>A description of any analysis intended to compare treatment arms with respect to efficacy or safety at any time prior to the formal completion of a trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Interim Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Multiplicity Adjustments" nciodm:ExtCodeID="C218810">
                    <ich:ICHDefinition>A description of the statistical adjustments needed to limit the probability of false positive findings in trials where there are multiple simultaneous hypotheses.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Multiplicity Adjustments</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other Analyses" nciodm:ExtCodeID="C218809">
                    <ich:ICHDefinition>A description of the analyses that are different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Safety Analyses" nciodm:ExtCodeID="C218808">
                    <ich:ICHDefinition>A description of the analyses of relevant safety variables, including adverse events of special interest.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Safety Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sample Size Determination" nciodm:ExtCodeID="C115467">
                    <ich:ICHDefinition>A statistical calculation to determine the number of participants required for the primary analysis, which should be large enough to provide a reliable answer to the questions addressed and should be determined by the primary objective of the trial. If the sample size is determined on some other basis, then this should be made clear and justified.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Sample Size Calculation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sensitivity Analysis" nciodm:ExtCodeID="C218480">
                    <ich:ICHDefinition>A description of the series of analyses conducted to explore the robustness of inferences from the main estimator to deviations from its underlying modeling assumptions and limitations in the data.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Treatment Effect Sensitivity Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Statistical Analysis Method" nciodm:ExtCodeID="C218482">
                    <ich:ICHDefinition>A description of the statistical model, hypothesis, and methods of analyses for each objective within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial-Related Statistical Analysis Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Supplementary Analysis" nciodm:ExtCodeID="C218481">
                    <ich:ICHDefinition>A description of the analyses that are conducted in addition to the main and sensitivity analysis with the intent to provide additional insights into the understanding of the treatment effect.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Treatment Effect Supplementary Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 10 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 10 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 10 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217352.ICH M11 Section 11 Terminology" Name="ICH M11 Section 11 Terminology" DataType="text" nciodm:ExtCodeID="C217352">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 11 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Committees" nciodm:ExtCodeID="C218819">
                    <ich:ICHDefinition>A description of the type and administrative structure of any committee associated with the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Committee Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Criteria for Early Closure" nciodm:ExtCodeID="C218829">
                    <ich:ICHDefinition>The requirements that must be met in order to close a trial site prematurely.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Criteria for Early Trial Site Closure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Data Dissemination" nciodm:ExtCodeID="C218831">
                    <ich:ICHDefinition>A description of whether and which public databases the clinical trial, and results if applicable, will be registered.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Data Dissemination</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Data Governance" nciodm:ExtCodeID="C218822">
                    <ich:ICHDefinition>A description of the key processes to ensure data integrity, traceability and security, in order to enable accurate collection, reporting, monitoring, transfer, retention, access and publication.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Data Governance</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Data Protection" nciodm:ExtCodeID="C218823">
                    <ich:ICHDefinition>A description of the measures taken to protect the privacy and confidentiality of person information of trial participants in accordance with applicable regulatory requirements on personal data protection and any measures that should be taken in case of a data security breach.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Data Protection</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Decision Rights for Site Closure" nciodm:ExtCodeID="C218828">
                    <ich:ICHDefinition>A description of the legal principles of entitlement for the sponsor to close a trial site, or for the investigator to initiate the closure of a trial site.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Decision Rights for Trial Site Closure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Assent Process" nciodm:ExtCodeID="C218815">
                    <ich:ICHDefinition>A description of the assent process for those individuals unable to give informed consent on their own behalf, to participate in the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Assent Process</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Emergency Consent Process" nciodm:ExtCodeID="C218816">
                    <ich:ICHDefinition>A type of informed consent process that may occur during an emergency situation in which the participant or their legally authorised representative is not available to give consent.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Emergency Consent Process</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Informed Consent Process" nciodm:ExtCodeID="C184390">
                    <ich:ICHDefinition>The procedure by which informed consent is obtained and documented by means of a written, signed, and dated informed consent form. This process may include obtaining assent from participants with legally authorised representatives.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Informed Consent Process</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Identification of Source Data" nciodm:ExtCodeID="C125442">
                    <ich:ICHDefinition>A description of how trial-related source data will be identified.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Clinical Trial Source Data Documentation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Informed Consent for Rescreening" nciodm:ExtCodeID="C218817">
                    <ich:ICHDefinition>A description of the consent requirements for participants in the event of screen failure and rescreening.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Informed Consent Requirements for Rescreening</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Informed Consent for Use of Remaining Samples in Exploratory Research" nciodm:ExtCodeID="C218818">
                    <ich:ICHDefinition>A description of the consent requirements for exploratory research using the remainder of mandatory samples. If applicable, this may include text in the original consent that address the use of remaining samples or additional text.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Informed Consent Requirements for Use of Remaining Samples in Exploratory Research</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Insurance and Indemnity" nciodm:ExtCodeID="C218820">
                    <ich:ICHDefinition>A concise summary of the arrangements for participants insurance and indemnity as required by the applicable regulatory body.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Insurance and Indemnity Summary</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigator Expectations for Source Data" nciodm:ExtCodeID="C218825">
                    <ich:ICHDefinition>A description of the obligations of the investigator with respect to maintaining and ensuring availability of the source data.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigator Expectations for Source Data</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigator Responsibilities" nciodm:ExtCodeID="C218813">
                    <ich:ICHDefinition>A description of the obligations of the investigator with respect to the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigator Responsibilities</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Deviations" nciodm:ExtCodeID="C218827">
                    <ich:ICHDefinition>A description of plans for detecting, reviewing, and reporting any deviations from the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Deviation Management</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Regulatory and Ethical Considerations" nciodm:ExtCodeID="C218811">
                    <ich:ICHDefinition>Careful thought or deliberation related to the regulatory and ethical aspects of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Regulatory and Ethical Consideration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Responsibilities Following Early Site Closure" nciodm:ExtCodeID="C218830">
                    <ich:ICHDefinition>The responsibilities of the sponsor and/or investigator following an unplanned early termination or suspension of the trial at an individual site.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Responsibilities Following Early Trial Site Closure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Risk-Based Quality Management" nciodm:ExtCodeID="C218821">
                    <ich:ICHDefinition>A description of how potential risks and critical to quality factors associated with the trial will be identified and handled.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Risk-Based Quality Management</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Source Data Introduction" nciodm:ExtCodeID="C218824">
                    <ich:ICHDefinition>A description of trial-related source data including the importance of source data maintenance and expectations for data traceability.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial-Related Source Data Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor Responsibilities" nciodm:ExtCodeID="C218814">
                    <ich:ICHDefinition>A description of the obligations of the sponsor with respect to the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Sponsor Responsibilities</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Monitor Expectations for Source Data" nciodm:ExtCodeID="C218826">
                    <ich:ICHDefinition>A description of the obligations of the trial monitor with respect to maintaining and ensuring availability of the source data.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Monitor Expectations for Source Data</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Oversight" nciodm:ExtCodeID="C218812">
                    <ich:ICHDefinition>A description of the planned processes and procedures to govern and conduct a clinical trial in order to protect the rights, safety and welfare of the trial participants.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Oversight Procedure Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 11 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 11 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 11 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217353.ICH M11 Section 12 Terminology" Name="ICH M11 Section 12 Terminology" DataType="text" nciodm:ExtCodeID="C217353">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 12 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Amendment Identifier" nciodm:ExtCodeID="C218477">
                    <ich:ICHDefinition>A sequence of characters used to uniquely identify a protocol amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Amendment Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Approximate Enrolled At Time of Sponsor Approval" nciodm:ExtCodeID="C218478">
                    <ich:ICHDefinition>The value (expressed either numerically or as a percentage) for the estimated number of participants enrolled at the time of the protocol amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Approximate Participant Enrollment At Time of Sponsor Approval</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Brief Rationale for Change" nciodm:ExtCodeID="C181233">
                    <ich:ICHDefinition>The brief reason for the change introduced in the current or prior version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Brief Rationale for Protocol Change</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Clinical Laboratory Tests" nciodm:ExtCodeID="C25294">
                    <ich:ICHDefinition>Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Laboratory Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Country/Region Identifier" nciodm:ExtCodeID="C218832">
                    <ich:ICHDefinition>A sequence of characters used to identify and/or name a country or region.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Country and/or Region Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Country/Region-Specific Protocol Clarifications" nciodm:ExtCodeID="C218834">
                    <ich:ICHDefinition>A description of any country or region-specific clarifications related to a protocol item.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Country and/or Region-Specific Protocol Clarifications Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Country/Region-Specific Requirements" nciodm:ExtCodeID="C218833">
                    <ich:ICHDefinition>A description of any country or region-specific requirements related to the trial but not related to individual items in the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Country and/or Region-Specific Trial Requirements</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Change" nciodm:ExtCodeID="C218483">
                    <ich:ICHDefinition>A description of the change introduced in the current or prior version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Protocol Change</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Prior Protocol Amendment(s)" nciodm:ExtCodeID="C218835">
                    <ich:ICHDefinition>An indication as to whether the protocol has not been amended, is the first protocol amendment, or a statement that the protocol has been amended previously.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Prior Protocol Amendment Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Section # and Name of Change" nciodm:ExtCodeID="C218479">
                    <ich:ICHDefinition>The protocol section number and name containing the change introduced in the current or prior version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Change Section Number and Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Specify Alternative Location" nciodm:ExtCodeID="C218836">
                    <ich:ICHDefinition>The physical or virtual location of the overview of changes from each prior amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Alternative Location of Protocol Changes</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor Approval Date" nciodm:ExtCodeID="C132352">
                    <ich:ICHDefinition>The date that the sponsor approved the current version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Approval by Sponsor Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 12 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 12 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 12 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217354.ICH M11 Section 13 Terminology" Name="ICH M11 Section 13 Terminology" DataType="text" nciodm:ExtCodeID="C217354">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 13 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Glossary of Terms and Abbreviations" nciodm:ExtCodeID="C218837">
                    <ich:ICHDefinition>A list of terms with their abbreviations and/or definitions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Glossary of Terms and Abbreviations</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 13 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 13 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 13 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217355.ICH M11 Section 14 Terminology" Name="ICH M11 Section 14 Terminology" DataType="text" nciodm:ExtCodeID="C217355">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 14 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="References" nciodm:ExtCodeID="C184397">
                    <ich:ICHDefinition>The curated list of sources that are cited within the reference section of the document.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Reference List</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 14 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 14 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 14 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217343.ICH M11 Section 2 Terminology" Name="ICH M11 Section 2 Terminology" DataType="text" nciodm:ExtCodeID="C217343">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 2 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Benefit Summary" nciodm:ExtCodeID="C218724">
                    <ich:ICHDefinition>A short textual description containing the potential physical, psychological, social, legal, and other benefits to the trial participant.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Participant Benefit Summary</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Overall Risk-Benefit Assessment" nciodm:ExtCodeID="C218725">
                    <ich:ICHDefinition>A short textual description containing the risks and benefits associated with participation in the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Overall Risk-Benefit Assessment Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Purpose of Trial" nciodm:ExtCodeID="C146997">
                    <ich:ICHDefinition>The overall rationale, reason, or intention of the clinical trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Purpose</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial-specific Intervention Risks and Mitigations" nciodm:ExtCodeID="C218721">
                    <ich:ICHDefinition>A description of the potential risks associated with the trial interventions and mitigation strategies to be employed within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial-specific Intervention Risks and Mitigation Strategy Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial-specific Other Risks and Mitigations" nciodm:ExtCodeID="C218723">
                    <ich:ICHDefinition>A description of the potential risks associated with the trial procedures and mitigation strategies to be employed within the trial that are different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial-specific Other Risks and Mitigation Strategy Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial-specific Procedure Risks and Mitigations" nciodm:ExtCodeID="C218722">
                    <ich:ICHDefinition>A description of the potential risks associated with the trial procedures and mitigation strategies to be employed within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial-specific Procedure Risks and Mitigation Strategy Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 2 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 2 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 2 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217344.ICH M11 Section 3 Terminology" Name="ICH M11 Section 3 Terminology" DataType="text" nciodm:ExtCodeID="C217344">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 3 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Description of Intercurrent Event" nciodm:ExtCodeID="C188856">
                    <ich:ICHDefinition>A description of the intercurrent event.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Intercurrent Event Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Endpoint" nciodm:ExtCodeID="C25212">
                    <ich:ICHDefinition>The variable to be obtained for each patient that is required to address the clinical question. The specification of the variable might include whether the patient experiences an intercurrent event.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>End Point</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Exploratory Objective" nciodm:ExtCodeID="C163559">
                    <ich:ICHDefinition>The exploratory reason for performing a study in terms of the scientific questions to be answered by the analysis of data collected during the study.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Exploratory Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Intercurrent Event Strategy" nciodm:ExtCodeID="C188857">
                    <ich:ICHDefinition>A description of the planned strategy to address intercurrent events.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Intercurrent Event Strategy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Population" nciodm:ExtCodeID="C70833">
                    <ich:ICHDefinition>The population of patients targeted by the clinical question. This will be represented by the entire trial population, a subgroup defined by a particular characteristic measured at baseline, or a principal stratum defined by the occurrence (or non-occurrence, depending on context) of a specific intercurrent event.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Population</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Population-Level Summary" nciodm:ExtCodeID="C188853">
                    <ich:ICHDefinition>Population level summary for the clinical endpoint of interest, which provides a basis for comparison between treatment conditions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Population-Level Summary</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Primary Objective" nciodm:ExtCodeID="C85826">
                    <ich:ICHSynonym>Study Primary Objective</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Primary Objective</ich:ICHSynonym>
                    <ich:ICHDefinition>The principle reason for performing a study in terms of the scientific questions to be answered by the analysis of data collected during the study.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Primary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Secondary Objective" nciodm:ExtCodeID="C85827">
                    <ich:ICHSynonym>Study Secondary Objective</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Secondary Objective</ich:ICHSynonym>
                    <ich:ICHDefinition>The secondary reason for performing a study in terms of the scientific questions to be answered by the analysis of data collected during the study.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Secondary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Treatment" nciodm:ExtCodeID="C49236">
                    <ich:ICHDefinition>The treatment condition of interest and, as appropriate, the alternative treatment condition to which comparison will be made (referred to as &quot;treatment&quot; through the remainder of this document). These might be individual interventions, combinations of interventions administered concurrently, e.g. as add-on to standard of care, or might consist of an overall regimen involving a complex sequence of interventions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Therapeutic Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 3 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 3 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 3 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217345.ICH M11 Section 4 Terminology" Name="ICH M11 Section 4 Terminology" DataType="text" nciodm:ExtCodeID="C217345">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 4 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Access to Trial Intervention after End of Trial" nciodm:ExtCodeID="C218738">
                    <ich:ICHDefinition>A narrative description containing information about whether and how trial participants have access to the trial interventions after the trial ends.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Access to Trial Intervention after End of Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Additional Description of Trial Design" nciodm:ExtCodeID="C218728">
                    <ich:ICHDefinition>An extra or further textual description of the trial design.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Additional Description of Trial Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Level and Method of Blinding" nciodm:ExtCodeID="C218727">
                    <ich:ICHDefinition>A description of the level of awareness of the study participants and/or personnel to the respective intervention(s) or assessments being observed, received or administered, and the methodology by which study participants or personnel are blinded.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Level and Method of Blinding</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Trial Duration" nciodm:ExtCodeID="C218726">
                    <ich:ICHDefinition>A description of the trial duration.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Trial Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="End of Trial" nciodm:ExtCodeID="C218737">
                    <ich:ICHDefinition>A description containing a concise explanation, any local regulatory requirements and considerations, extensions, follow-up, and analysis for the trial end.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>End of Trial Explanation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Method of Assignment to Trial Intervention" nciodm:ExtCodeID="C218475">
                    <ich:ICHDefinition>The technique used to assign trial participants to a trial intervention or trial arm.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Intervention Assignment Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Overall Description of Trial Design and Description of Intervention Model" nciodm:ExtCodeID="C147139">
                    <ich:ICHDefinition>A description summarizing the overall trial design and intervention model.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Design Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Overall Rationale for Trial Design" nciodm:ExtCodeID="C142705">
                    <ich:ICHDefinition>An explanation as to the scientific reasons for the choice of the trial design.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Design Rationale</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rationale for Adaptive or Novel Trial Design" nciodm:ExtCodeID="C218733">
                    <ich:ICHDefinition>An explanation as to the scientific reasons for why an adaptive or novel trial design was chosen for the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rationale for Adaptive or Novel Trial Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rationale for Control Type" nciodm:ExtCodeID="C218731">
                    <ich:ICHDefinition>An explanation as to the scientific reasons for the choice of the control types used in the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rationale for Trial Control Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rationale for Estimand(s)" nciodm:ExtCodeID="C218730">
                    <ich:ICHDefinition>An explanation as to the scientific reasons for the choice of the trial estimand(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rationale for Trial Estimand</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rationale for Interim Analysis" nciodm:ExtCodeID="C218734">
                    <ich:ICHDefinition>An explanation for the analysis comparing intervention groups at any time before the formal completion of the trial, usually before recruitment is complete. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rationale for Interim Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rationale for Intervention Model" nciodm:ExtCodeID="C215629">
                    <ich:ICHDefinition>An explanation as to the scientific reasons for why the intervention model was chosen for the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Interventional Study Design Rationale</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rationale for Other Trial Design Aspects" nciodm:ExtCodeID="C218735">
                    <ich:ICHDefinition>An explanation as to the scientific reasons for additional trial design considerations that are different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rationale for Other Trial Design Aspects</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rationale for Trial Duration" nciodm:ExtCodeID="C218732">
                    <ich:ICHDefinition>An explanation as to the scientific reasons for the trial duration.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rationale for Trial Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Stakeholder Input into Design" nciodm:ExtCodeID="C218729">
                    <ich:ICHDefinition>A description of the way in which trial stakeholders were consulted when determining the trial design and how that input was applied.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Stakeholder Input into Trial Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Start of Trial" nciodm:ExtCodeID="C218736">
                    <ich:ICHDefinition>A description containing a concise explanation, any local regulatory requirements and considerations, extensions, follow-up, and analysis for the trial start.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Start of Trial Explanation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Stopping Rules" nciodm:ExtCodeID="C142698">
                    <ich:ICHDefinition>A criterion that, when met by the accumulating data, indicates that the trial can or should be stopped early to avoid putting participants at risk unnecessarily or because the intervention effect is so great that further data collection is unnecessary.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Stopping Rules</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 4 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 4 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 4 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217346.ICH M11 Section 5 Terminology" Name="ICH M11 Section 5 Terminology" DataType="text" nciodm:ExtCodeID="C217346">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 5 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Caffeine, Alcohol, Tobacco, and Other Restrictions" nciodm:ExtCodeID="C218744">
                    <ich:ICHDefinition>A description of the restrictions related to participant intake of caffeine, alcohol, tobacco, and other habit-forming substances during the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Participant Caffeine, Alcohol, Tobacco, and Other Substance Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Contraception Requirements" nciodm:ExtCodeID="C218741">
                    <ich:ICHDefinition>A description of the requirements for the prevention of conception or impregnation by the use of devices or drugs or surgery within a context of a trial, or state not applicable.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Participant Contraception Requirements</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Definitions Related to Childbearing Potential" nciodm:ExtCodeID="C218740">
                    <ich:ICHDefinition>A concise explanation of the meaning of participants of childbearing potential and non-childbearing potential within the context of a trial, or state not applicable.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Definitions Related to Trial Participant Childbearing Potential</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Trial Population and Rationale" nciodm:ExtCodeID="C218739">
                    <ich:ICHDefinition>A description of the rationale for selection of trial population describing how the selected population can meet the trial objectives and how the enrollment criteria reflect the targeted populations.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Trial Population and Rationale</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Exclusion Criterion" nciodm:ExtCodeID="C25370">
                    <ich:ICHDefinition>List of characteristics in a protocol, any one of which excludes a potential participant from participation in a study. (CDISC glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Exclusion Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Inclusion Criterion" nciodm:ExtCodeID="C25532">
                    <ich:ICHDefinition>The criteria in a protocol that prospective participants must meet to be eligible for participation in a study. (CDISC glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Inclusion Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Lifestyle Restrictions" nciodm:ExtCodeID="C218742">
                    <ich:ICHDefinition>A description of the restrictions related to trial participant lifestyle such as diet, substance intake, and physical or other daily activities.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Participant Lifestyle Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Meals and Dietary Restrictions" nciodm:ExtCodeID="C218743">
                    <ich:ICHDefinition>A description of the restrictions related to participant diet during the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Participant Meals and Dietary Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other Activity Restrictions" nciodm:ExtCodeID="C218746">
                    <ich:ICHDefinition>An activity restriction that is different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other Activity Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Physical Activity Restrictions" nciodm:ExtCodeID="C218745">
                    <ich:ICHDefinition>A description of the restrictions related to participant physical activity during the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Participant Physical Activity Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rescreening" nciodm:ExtCodeID="C179373">
                    <ich:ICHDefinition>The process of active consideration of participants for enrollment in a trial, for those potential participants who have failed a prior screening attempt.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rescreening</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Screen Failure" nciodm:ExtCodeID="C49628">
                    <ich:ICHDefinition>The potential participant who does not meet eligibility (inclusion/exclusion) criteria during the screening period.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Screen Failure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 5 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 5 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 5 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217347.ICH M11 Section 6 Terminology" Name="ICH M11 Section 6 Terminology" DataType="text" nciodm:ExtCodeID="C217347">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 6 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Accountability of Investigational Trial Intervention" nciodm:ExtCodeID="C176267">
                    <ich:ICHDefinition>The act or process for documenting the storage, inventory tracking, and disposition of the investigational trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Product Accountability</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Arm Name" nciodm:ExtCodeID="C93729">
                    <ich:ICHDefinition>The literal identifier (i.e. distinctive designation) for the arm.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Arm Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Arm Type" nciodm:ExtCodeID="C172457">
                    <ich:ICHDefinition>A characterisation or classification of the study arm.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Arm Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Background Trial Interventions" nciodm:ExtCodeID="C165822">
                    <ich:ICHDefinition>Medicinal products that are administered to each clinical trial participant, regardless of randomization group, a) to treat the indication which is the object of the study, or b) required in the protocol as part of standard care for a condition that is not the indication under investigation, and is relevant for the clinical trial design. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Background Treatment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Concomitant Therapy" nciodm:ExtCodeID="C53630">
                    <ich:ICHDefinition>Any pharmaceutical agent, other than the trial interventions, that is administered to or used by the participant prior to or during a specified time period.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Concomitant Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Investigational Trial Intervention" nciodm:ExtCodeID="C218751">
                    <ich:ICHDefinition>A description of the investigational trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Investigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Noninvestigational Trial Interventions" nciodm:ExtCodeID="C218759">
                    <ich:ICHDefinition>A description of the noninvestigational trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Noninvestigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of the Overview of Trial intervention or a Heading for the Optional Table" nciodm:ExtCodeID="C218747">
                    <ich:ICHDefinition>A free text description of the trial intervention; alternatively can be used as a heading for a table containing information about the trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Intervention Overview or Informational Table Header</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Dosage Level(s)" nciodm:ExtCodeID="C94394">
                    <ich:ICHDefinition>Specified quantity of a medicine, to be taken at one time or at stated intervals.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Cumulative Dose</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Dosage Strength(s)" nciodm:ExtCodeID="C142517">
                    <ich:ICHDefinition>The strength of a drug product, which indicates the amount of each active ingredient in a given dosage form, measured in units of volume or concentration.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Dose Strength</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Emergency Unblinding at the Site" nciodm:ExtCodeID="C218757">
                    <ich:ICHDefinition>A description of the methodology used for unblinding of the trial treatment in the case of a sudden unforeseen crisis that requires immediate medical care of the participant.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Emergency Unblinding at the Site</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="IMP or NIMP" nciodm:ExtCodeID="C218749">
                    <ich:ICHDefinition>An indication as to whether the investigational intervention is an investigational medicinal product or an auxiliary medicinal product.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>IMP or NIMP Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Intervention Name" nciodm:ExtCodeID="C177930">
                    <ich:ICHDefinition>The literal identifier (i.e. distinctive designation) for the study intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Intervention Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Intervention Type" nciodm:ExtCodeID="C98747">
                    <ich:ICHDefinition>The kind of product or procedure studied in a trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Intervention Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigational Trial Intervention Adherence" nciodm:ExtCodeID="C218758">
                    <ich:ICHDefinition>A description of the measures taken to ensure trial intervention adherence, including mandatory documentation to be filled out and the source data that will be used to document investigational trial intervention compliance.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigational Trial Intervention Adherence Measures Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigational Trial Intervention Administration" nciodm:ExtCodeID="C218753">
                    <ich:ICHDefinition>The way in which the investigational trial intervention is dispensed, applied, or tendered to the trial participant.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigational Trial Intervention Administration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigational Trial Intervention Dose Modification" nciodm:ExtCodeID="C218754">
                    <ich:ICHDefinition>A change, alteration, or adjustment to the dose of an investigational trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigational Trial Intervention Dose Modification</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Management of Investigational Trial Intervention Overdose" nciodm:ExtCodeID="C218755">
                    <ich:ICHDefinition>A description of how a potential investigational trial intervention overdose will be handled.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Management of Investigational Trial Intervention Overdose</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Measures to Maintain Blinding" nciodm:ExtCodeID="C189349">
                    <ich:ICHDefinition>A description of the measures taken to ensure the blinding is maintained.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Blinding Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other Noninvestigational Trial Intervention" nciodm:ExtCodeID="C218761">
                    <ich:ICHDefinition>A noninvestigational intervention that is different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other Noninvestigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Participant Assignment to Investigational Trial Intervention" nciodm:ExtCodeID="C218756">
                    <ich:ICHDefinition>The technique used to assign trial participants to a trial arm.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Participant Assignment to Investigational Intervention Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Permitted Concomitant Therapy" nciodm:ExtCodeID="C218763">
                    <ich:ICHDefinition>Concomitant therapy that is approved for use in the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Permitted Concomitant Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Pharmaceutical Dose Form" nciodm:ExtCodeID="C42636">
                    <ich:ICHDefinition>Physical characteristics of a drug product, (e.g., tablet, capsule, or solution) that contains a drug substance, generally-but not necessarily-in association with one or more other ingredients. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Pharmaceutical Dosage Form</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Preparation of Investigational Trial Intervention" nciodm:ExtCodeID="C176274">
                    <ich:ICHDefinition>The way in which the investigational trial intervention is prepared for use or administration to the trial participant.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Product Preparation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Prohibited Concomitant Therapy" nciodm:ExtCodeID="C218762">
                    <ich:ICHDefinition>Concomitant therapy that is banned from use in the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Prohibited Concomitant Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Randomisation" nciodm:ExtCodeID="C25196">
                    <ich:ICHDefinition>The process of assigning trial participants to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rationale for Investigational Trial Intervention Dose and Regimen" nciodm:ExtCodeID="C218752">
                    <ich:ICHDefinition>An explanation as to the scientific reasons for the choice of the trial intervention dose and dose regimen.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rationale for Investigational Trial Intervention Dose and Regimen</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Regimen/Treatment Period/Vaccination Regimen" nciodm:ExtCodeID="C15697">
                    <ich:ICHDefinition>A description of the schedule and periodicity of a treatment or vaccination regimen.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Treatment Regimen</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rescue Therapy" nciodm:ExtCodeID="C218760">
                    <ich:ICHDefinition>Any rescue medications, treatments, and/or procedures identified in the protocol as those that may be administered to participants when the efficacy of the investigational intervention is not satisfactory, its effect is too great and is likely to cause a hazard to the participant, or to manage an emergency situation. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rescue Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Route of Administration" nciodm:ExtCodeID="C38114">
                    <ich:ICHDefinition>Path by which the pharmaceutical product is taken into or makes contact with the body.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Route of Administration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sourcing" nciodm:ExtCodeID="C218750">
                    <ich:ICHDefinition>An indication as to whether the investigational intervention is centrally or locally sourced.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigational Intervention Sourcing Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Storage and Handling of Investigational Trial Intervention" nciodm:ExtCodeID="C115525">
                    <ich:ICHDefinition>A narrative description containing information about the handling, storage, and distribution of investigational trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Clinical Trial Investigational Product Handling Instruction Documentation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Use" nciodm:ExtCodeID="C218748">
                    <ich:ICHDefinition>The reason or intention for the use of the trial intervention within the trial arm.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Intervention Intent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 6 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 6 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 6 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217348.ICH M11 Section 7 Terminology" Name="ICH M11 Section 7 Terminology" DataType="text" nciodm:ExtCodeID="C217348">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 7 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Management of Loss to Follow-Up" nciodm:ExtCodeID="C218768">
                    <ich:ICHDefinition>The mitigation strategies to be employed for the loss or lack of continuation of a participant to follow-up, including the frequency by which follow-up occurs.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Management of Loss to Follow-Up</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Participant Discontinuation or Withdrawal from Trial" nciodm:ExtCodeID="C218767">
                    <ich:ICHDefinition>The rationale for why the participant either discontinued or withdrew from the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Subject Discontinuation Rationale</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Permanent Discontinuation of Trial Intervention" nciodm:ExtCodeID="C218764">
                    <ich:ICHDefinition>The requirements that must be met in order to permanently discontinue the administration of trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Requirements for Permanent Discontinuation of Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rechallenge" nciodm:ExtCodeID="C218766">
                    <ich:ICHDefinition>The requirements that must be met in order to reintroduce previously withdrawn or temporarily discontinued medical intervention in the same participant.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rechallenge Requirement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Temporary Discontinuation of Trial Intervention" nciodm:ExtCodeID="C218765">
                    <ich:ICHDefinition>The requirements that must be met in order to temporarily discontinue the administration of trial intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Requirements for Temporary Discontinuation of Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 7 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 7 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 7 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217349.ICH M11 Section 8 Terminology" Name="ICH M11 Section 8 Terminology" DataType="text" nciodm:ExtCodeID="C217349">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 8 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Baseline Assessments and Procedures" nciodm:ExtCodeID="C218771">
                    <ich:ICHDefinition>Trial assessments and procedures related to the baseline epoch of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Baseline Assessments and Procedures Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Clinical Laboratory Assessments" nciodm:ExtCodeID="C218774">
                    <ich:ICHDefinition>Trial-related laboratory assessments and procedures.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Clinical Laboratory Assessment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Efficacy Assessments and Procedures" nciodm:ExtCodeID="C218772">
                    <ich:ICHDefinition>Trial assessments and procedures related to trial intervention efficacy.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Efficacy Assessments and Procedures Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Electrocardiograms" nciodm:ExtCodeID="C168186">
                    <ich:ICHDefinition>The procedures for the recordings produced by the variations in electrical potential caused by electrical activity of the heart muscle and detected at the body surface, as a method for studying the action of the heart muscle.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Electrocardiogram</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Genetics and Pharmacogenomics" nciodm:ExtCodeID="C218777">
                    <ich:ICHDefinition>A narrative description containing information about the collection, use, and retention of biospecimens, and their use in genetic and pharmacogenomic biomarker assessments within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Genetics and Pharmacogenomics Assessment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Immunogenicity Assessments" nciodm:ExtCodeID="C218780">
                    <ich:ICHDefinition>A narrative description containing information about the collection, use, and retention of biospecimens, and their use in immunogenicity assessments within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Immunogenicity Assessment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Medical Resource Utilisation and Health Economics" nciodm:ExtCodeID="C176849">
                    <ich:ICHDefinition>A narrative description containing information about medical resource utilisation and the health outcome measures, collection method and participant burden.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Healthcare Utilization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other Biomarkers" nciodm:ExtCodeID="C218779">
                    <ich:ICHDefinition>A narrative description containing information about the collection, use, and retention of biospecimens, and their use in other biomarker assessments within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other Biomarker Assessment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Pharmacodynamic Biomarkers" nciodm:ExtCodeID="C218778">
                    <ich:ICHDefinition>A narrative description containing information about the collection, use, and retention of biospecimens, and their use in pharmacodynamic biomarker assessments within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Pharmacodynamics Assessment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Pharmacokinetics" nciodm:ExtCodeID="C218776">
                    <ich:ICHDefinition>A narrative description containing information about the collection, use, and retention of biospecimens, and their use in pharmacokinetic assessments within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Pharmacokinetic Assessment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Physical Examination" nciodm:ExtCodeID="C20989">
                    <ich:ICHDefinition>The procedures for a physical examination of the body and its functions to be conducted for the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Physical Examination</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Pregnancy Testing" nciodm:ExtCodeID="C92949">
                    <ich:ICHDefinition>Any examination performed to assess if a female is gravid.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Pregnancy Test</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Safety Assessments and Procedures" nciodm:ExtCodeID="C218773">
                    <ich:ICHDefinition>A description of the assessments and procedures related to participant safety within the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Safety Assessments and Procedures Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Screening Assessments and Procedures" nciodm:ExtCodeID="C218770">
                    <ich:ICHDefinition>Trial assessments and procedures related to the screening epoch of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Screening Assessments and Procedures Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Suicidal Ideation and Behaviour Risk Monitoring" nciodm:ExtCodeID="C218775">
                    <ich:ICHDefinition>A description of data collection procedures and analysis related to suicidal ideation and behaviour risk monitoring.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Suicidal Ideation and Behaviour Risk Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Assessments and Procedures Considerations" nciodm:ExtCodeID="C218769">
                    <ich:ICHDefinition>A description of general considerations applicable across trial assessments and procedures.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Assessments and Procedures Considerations Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Vital Signs" nciodm:ExtCodeID="C154628">
                    <ich:ICHDefinition>The procedures for measurements of the body&apos;s basic functions that provide insight into the health status of the person.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Vital Signs</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 8 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 8 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 8 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217350.ICH M11 Section 9 Terminology" Name="ICH M11 Section 9 Terminology" DataType="text" nciodm:ExtCodeID="C217350">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in section 9 of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Adverse Events of Special Interest" nciodm:ExtCodeID="C217358">
                    <ich:ICHSynonym>AESI</ich:ICHSynonym>
                    <ich:ICHDefinition>A description of the processes and procedures used to define, measure, confirm, and report the occurrence of adverse events that are of special interest to the specific trial, or state not applicable.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Adverse Event of Special Interest</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Back-up Method for Reporting" nciodm:ExtCodeID="C218790">
                    <ich:ICHDefinition>A description of alternative techniques by which trial related events, such as adverse events, serious adverse events, product complaints, medical device product complaints, and pregnancy and postpartum events, are reported to the sponsor and/or regulatory authority.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Event Back-Up Reporting Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Causality" nciodm:ExtCodeID="C82552">
                    <ich:ICHDefinition>The description of the degree of causality (attributability) between a trial intervention and an event.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Causality</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Definitions of Adverse Events" nciodm:ExtCodeID="C218476">
                    <ich:ICHDefinition>A concise explanation of the meaning of adverse events within the context of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Definition of Adverse Events</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Definitions of Medical Device Product Complaints" nciodm:ExtCodeID="C218783">
                    <ich:ICHDefinition>A concise explanation of the meaning of medical device product complaints within the context of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Definition of Medical Device Product Complaints</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Definitions of Product Complaints" nciodm:ExtCodeID="C218782">
                    <ich:ICHDefinition>A concise explanation of the meaning of product complaints within the context of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Definition of Product Complaints</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Definitions of Serious Adverse Events" nciodm:ExtCodeID="C218781">
                    <ich:ICHDefinition>A concise explanation of the meaning of serious adverse events within the context of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Definition of Serious Adverse Events</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Disease-related Events or Outcomes Not Qualifying as AEs or SAEs" nciodm:ExtCodeID="C218797">
                    <ich:ICHDefinition>A description of events or outcomes related to the trial disease indication but not qualifying as adverse events or serious adverse events within the trial, or state not applicable.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Disease-related Events or Outcomes Not Qualifying as Adverse Events or Serious Adverse Events</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Event Collection and Reporting Timing" nciodm:ExtCodeID="C218791">
                    <ich:ICHDefinition>A description of the timing as it relates to the collection and reporting of trial related events, and the frequency of collection of those events to the sponsor or designee.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Event Collection and Reporting Timing Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Event Type" nciodm:ExtCodeID="C218784">
                    <ich:ICHDefinition>A characterisation or classification of trial-related safety events, such as adverse events, serious adverse events, product complaints, medical device product complaints, and pregnancy and postpartum events.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial-Related Safety Event Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Follow-up" nciodm:ExtCodeID="C218794">
                    <ich:ICHDefinition>A description of the procedures for follow-up, including the assessment tools that will be used to monitor an event and the duration of follow-up.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Event Follow-up Procedure Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Identification" nciodm:ExtCodeID="C218792">
                    <ich:ICHDefinition>A description of how trial-related events, such as adverse events, serious adverse events, product complaints, medical device product complaints, and pregnancy and postpartum events, will be identified.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial-Related Event Identification</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Method for Reporting" nciodm:ExtCodeID="C218789">
                    <ich:ICHDefinition>A description of the technique by which trial related events, such as adverse events, serious adverse events, product complaints, medical device product complaints, and pregnancy and postpartum events, are reported to the sponsor and/or regulatory authority.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Event Reporting Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Participants Who Become Pregnant During the Trial" nciodm:ExtCodeID="C218798">
                    <ich:ICHDefinition>A description of the processes and procedures used to collect pregnancy data for a trial participant who becomes pregnant while the participant is in the trial, as well as data collection about the foetus, neonate, infant, or child.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Participants Who Become Pregnant During the Trial Data Collection</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Participants Whose Partners Become Pregnant During the Trial" nciodm:ExtCodeID="C218799">
                    <ich:ICHDefinition>A description of the processes and procedures used to collect pregnancy data for a trial participant&apos;s partner, who becomes pregnant while the participant is in the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Participants Whose Partners Become Pregnant During the Trial Data Collection</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Recording" nciodm:ExtCodeID="C218793">
                    <ich:ICHDefinition>A description for the procedures used to document an event.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Event Recording Procedure Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Regulatory Reporting Requirements" nciodm:ExtCodeID="C218796">
                    <ich:ICHDefinition>A description of the requirements for the sponsor/designee to report adverse events, serious adverse events, pregnancy and postpartum events, and medical device product complaints, including the criteria for reporting, to the relevant regulatory authority.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Regulatory Reporting Requirements for Trial-Related Events</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Reportable Period End" nciodm:ExtCodeID="C218787">
                    <ich:ICHDefinition>The date on which reporting will cease for trial related events such as adverse events, serious adverse events, product complaints, medical device product complaints, and pregnancy and postpartum events.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Reportable Period End Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Reportable Period Start" nciodm:ExtCodeID="C218786">
                    <ich:ICHDefinition>The date on which reporting will begin for trial related events such as adverse events, serious adverse events, product complaints, medical device product complaints, and pregnancy and postpartum events.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Reportable Period Start Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Reporting" nciodm:ExtCodeID="C218795">
                    <ich:ICHDefinition>A description of the method and timelines for reporting adverse events, serious adverse events, pregnancy and postpartum events, and medical device product complaints to the sponsor.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Event Reporting Procedure Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Severity" nciodm:ExtCodeID="C25676">
                    <ich:ICHDefinition>The description of the intensity (severity) of an event.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Severity</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Situational Scope" nciodm:ExtCodeID="C218785">
                    <ich:ICHDefinition>A description of the specific circumstances and context in which safety events are collected and monitored.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Safety Event Situational Scope Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Special Safety Situations" nciodm:ExtCodeID="C218800">
                    <ich:ICHDefinition>A characterisation or classification of those trial specific situations that are associated with the trial intervention(s) and require regulatory reporting, but that do not qualify as an adverse event or serious adverse event for the given trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Special Safety Situation Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Timing for Reporting to Sponsor or Designee" nciodm:ExtCodeID="C218788">
                    <ich:ICHDefinition>A description of the timing window between trial related events and their reporting to the sponsor or designee.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Timing Description for Reporting to Sponsor or Designee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section 9 Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section 9 Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section 9 Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217357.ICH M11 Section Amendment Details Terminology" Name="ICH M11 Section Amendment Details Terminology" DataType="text" nciodm:ExtCodeID="C217357">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in the amendment details section of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Amendment Details" nciodm:ExtCodeID="C218694">
                    <ich:ICHDefinition>A written message within the study protocol that describes the amendment details, especially as to whether the protocol has been amended previously.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Amendment Details</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Amendment Scope Enrollment Description" nciodm:ExtCodeID="C218695">
                    <ich:ICHDefinition>The enrollment description as to whether the amendment scope applies globally, locally, or per cohort across the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Amendment Scope Enrollment Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Amendment Summary" nciodm:ExtCodeID="C42581">
                    <ich:ICHDefinition>A short description describing the changes introduced in the current version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Summary</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Approximate Enrolled At Time of Sponsor Approval" nciodm:ExtCodeID="C218478">
                    <ich:ICHDefinition>The value (expressed either numerically or as a percentage) for the estimated number of participants enrolled at the time of the protocol amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Approximate Participant Enrollment At Time of Sponsor Approval</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Brief Rationale for Change" nciodm:ExtCodeID="C181233">
                    <ich:ICHDefinition>The brief reason for the change introduced in the current or prior version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Brief Rationale for Protocol Change</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Briefly Explain Substantial Impact on Data" nciodm:ExtCodeID="C218701">
                    <ich:ICHDefinition>A short descriptive account of any substantial impacts on the reliability and robustness of the data generated in the clinical trial due to the protocol amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Brief Explanation of Substantial Impact on Study Data</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Briefly Explain Substantial Impact On Safety" nciodm:ExtCodeID="C218699">
                    <ich:ICHDefinition>A short descriptive account of any substantial impacts on the safety or rights of the participants due to the protocol amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Brief Explanation of Substantial Impact on Participant Safety</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Description of Change" nciodm:ExtCodeID="C218483">
                    <ich:ICHDefinition>A description of the change introduced in the current or prior version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Description of Protocol Change</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Is this amendment likely to have a substantial impact on the reliability and robustness of the data generated in the clinical trial?" nciodm:ExtCodeID="C218700">
                    <ich:ICHDefinition>An indication as to whether the amendment likely to have a substantial impact on the reliability and robustness of the data generated in the clinical trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Amendment Impacts Reliability and Robustness of Data Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Is this amendment likely to have a substantial impact on the safety or rights of the participants?" nciodm:ExtCodeID="C218698">
                    <ich:ICHDefinition>An indication as to whether the amendment is likely to have a substantial impact on the safety or rights of the participants.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Amendment Impacts Participant&apos;s Safety or Rights Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Primary Reason for Amendment" nciodm:ExtCodeID="C218696">
                    <ich:ICHDefinition>The rationale of greatest importance for the protocol amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Primary Reason for Protocol Amendment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Secondary Reason for Amendment" nciodm:ExtCodeID="C218697">
                    <ich:ICHDefinition>Additional rationale for the protocol amendment that is not considered the primary rationale.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Secondary Reason for Protocol Amendment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Section # and Name of Change" nciodm:ExtCodeID="C218479">
                    <ich:ICHDefinition>The protocol section number and name containing the change introduced in the current or prior version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Change Section Number and Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section Amendment Details Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section Amendment Details Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section Amendment Details Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217356.ICH M11 Section Title Page Terminology" Name="ICH M11 Section Title Page Terminology" DataType="text" nciodm:ExtCodeID="C217356">
                <Description>
                    <TranslatedText xml:lang="en">Terminology relevant to the data elements in the title page of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Amendment Identifier" nciodm:ExtCodeID="C218477">
                    <ich:ICHDefinition>A sequence of characters used to uniquely identify a protocol amendment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Amendment Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Amendment Scope" nciodm:ExtCodeID="C218673">
                    <ich:ICHDefinition>A description as to whether the amendment scope applies globally across the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Amendment Scope Global Applicability Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Approval Date or State Location Where Information Can be Found" nciodm:ExtCodeID="C218691">
                    <ich:ICHDefinition>The date that the sponsor approved the current or prior version of the protocol, or the physical or virtual location of the date on which the sponsor approved the current or prior version of the protocol, or state location where information can be found.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Approval Date or Location of Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Co-Sponsor Legal Address" nciodm:ExtCodeID="C218679">
                    <ich:ICHDefinition>The legally registered address of the trial co-sponsor.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Co-Sponsor Legal Address</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Co-Sponsor Name" nciodm:ExtCodeID="C218678">
                    <ich:ICHDefinition>The literal identifier (i.e., distinctive designation) of the trial co-sponsor.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Co-Sponsor Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="contact information for medical expert (as designated by sponsor) or state location where information can be found" nciodm:ExtCodeID="C218693">
                    <ich:ICHSynonym>Medical Monitor Contact Information</ich:ICHSynonym>
                    <ich:ICHDefinition>The contact information for the sponsor&apos;s representative who can advise on specific trial-related medical questions or problems, or state location where information can be found.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Designated Medical Expert Contact Information or Location of Contact Information</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Country Identifier" nciodm:ExtCodeID="C20108">
                    <ich:ICHDefinition>A sequence of characters used to identify and/or name the country.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Country Code</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Describe Method" nciodm:ExtCodeID="C218692">
                    <ich:ICHDefinition>The narrative text describing the technique used to approve the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Approval Method Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Device Manufacturer Address" nciodm:ExtCodeID="C218683">
                    <ich:ICHDefinition>The legally registered address of the device manufacturer.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Device Manufacturer Legal Address</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Device Manufacturer Name" nciodm:ExtCodeID="C218682">
                    <ich:ICHDefinition>The literal identifier (i.e., distinctive designation) of the organisation defined as being responsible for creating the device as stated on the package in which the product is supplied.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Device Manufacturer Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EU CT Number" nciodm:ExtCodeID="C218684">
                    <ich:ICHSynonym>EU Clinical Trial Number</ich:ICHSynonym>
                    <ich:ICHDefinition>A sequence of characters used to identify a clinical trial, as assigned by the Clinical Trials Information System (CTIS) of the European Medicines Agency.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>EU Clinical Trial Register Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="FDA IND Number" nciodm:ExtCodeID="C218685">
                    <ich:ICHSynonym>FDA Investigational New Drug Number</ich:ICHSynonym>
                    <ich:ICHDefinition>A sequence of characters used to identify a clinical trial under an Investigational New Drug (IND) application, as assigned by the US Food and Drug Administration.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>US FDA Investigational New Drug Application Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Full Title" nciodm:ExtCodeID="C132346">
                    <ich:ICHSynonym>Scientific Protocol Title</ich:ICHSynonym>
                    <ich:ICHDefinition>The formal descriptive name for the protocol that contains key elements of the study. (CDISC)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Official Protocol Title</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="IDE Number" nciodm:ExtCodeID="C218686">
                    <ich:ICHSynonym>FDA Investigational Device Exemption Application Number</ich:ICHSynonym>
                    <ich:ICHDefinition>A sequence of characters used to identify a clinical trial under an Investigational Device Exemption (IDE) application, as assigned by the US Food and Drug Administration.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>US FDA Investigational Device Exemption Application Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="jRCT Number" nciodm:ExtCodeID="C218687">
                    <ich:ICHSynonym>Japan Registry for Clinical Trials Number</ich:ICHSynonym>
                    <ich:ICHDefinition>A sequence of characters used to identify a clinical trial, as assigned by the Japan Registry for Clinical Trials (JRCT) of the Ministry of Health, Labour and Welfare (MHLW) in Japan.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Japan Registry for Clinical Trials Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Local Sponsor Address" nciodm:ExtCodeID="C218681">
                    <ich:ICHDefinition>The legally registered address of the sponsor&apos;s legal representative at a geographical region within which the sponsor has no legal presence.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Local Sponsor Legal Address</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Local Sponsor Name" nciodm:ExtCodeID="C218680">
                    <ich:ICHDefinition>The literal identifier (i.e., distinctive designation) of the sponsor&apos;s legal representative at a geographical region within which the sponsor has no legal presence.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Local Sponsor Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="NCT Number" nciodm:ExtCodeID="C172240">
                    <ich:ICHSynonym>National Clinical Trial Number</ich:ICHSynonym>
                    <ich:ICHDefinition>A sequence of characters used to identify a clinical trial, as assigned by the protocol registration and results (PRS) system of the US National Library of Medicine.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Clinicaltrials.gov Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="NMPA IND Number" nciodm:ExtCodeID="C218688">
                    <ich:ICHSynonym>NMPA Investigational New Drug Number</ich:ICHSynonym>
                    <ich:ICHDefinition>A sequence of characters used to identify a clinical trial under an Investigational New Drug (IND) application, as assigned by the Chinese National Medicinal Products Administration (NMPA).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>NMPA IND Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Nonproprietary Name(s)" nciodm:ExtCodeID="C97054">
                    <ich:ICHSynonym>Generic Name</ich:ICHSynonym>
                    <ich:ICHSynonym>Public Name</ich:ICHSynonym>
                    <ich:ICHDefinition>Drug name that is not protected by a trademark, usually descriptive of its chemical structure, and sometimes a public name. (ICH E2B)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Generic Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Original Protocol Indicator" nciodm:ExtCodeID="C218672">
                    <ich:ICHDefinition>An indication as to whether the protocol document reflects the original version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Original Protocol Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other Regulatory or Clinical Trial Identifier" nciodm:ExtCodeID="C218690">
                    <ich:ICHDefinition>A sequence of characters assigned by a regulatory agency or other health authority that is used to identify a clinical trial, and that is different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other Regulatory or Clinical Trial Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Proprietary Name(s)" nciodm:ExtCodeID="C71898">
                    <ich:ICHDefinition>A commercial name granted by an authority for use in marketing/registering a product.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Proprietary Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Region Identifier" nciodm:ExtCodeID="C218674">
                    <ich:ICHDefinition>A sequence of characters used to identify and/or name the region.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Region Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Site Identifier" nciodm:ExtCodeID="C83081">
                    <ich:ICHDefinition>A sequence of characters used to identify and/or name the study site.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Site Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor Confidentiality Statement" nciodm:ExtCodeID="C181236">
                    <ich:ICHSynonym>Protocol Confidentiality Statement</ich:ICHSynonym>
                    <ich:ICHDefinition>A written message within the study protocol that asserts a statement of non-disclosure, such that information contained within the protocol document may only be shared with authorised parties.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Confidentiality Statement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor Legal Address" nciodm:ExtCodeID="C218677">
                    <ich:ICHDefinition>The legally registered address of the trial sponsor.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Sponsor Legal Address</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor Name" nciodm:ExtCodeID="C70793">
                    <ich:ICHDefinition>The literal identifier (i.e., distinctive designation) of the trial sponsor.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Clinical Study Sponsor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor Protocol Identifier" nciodm:ExtCodeID="C132351">
                    <ich:ICHDefinition>A sequence of characters assigned by the sponsor that uniquely identifies a specific protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Sponsor Protocol Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor&apos;s Investigational Product Code(s)" nciodm:ExtCodeID="C218675">
                    <ich:ICHDefinition>A symbol or combination of symbols that are assigned by the sponsor to uniquely identify an experimental intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Sponsor&apos;s Investigational Product Code</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Acronym" nciodm:ExtCodeID="C94108">
                    <ich:ICHDefinition>Acronym or abbreviation used publicly to identify the clinical trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Protocol Version Acronym</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Phase" nciodm:ExtCodeID="C48281">
                    <ich:ICHDefinition>A stage in the clinical research and development of a therapy from first-in-human to post-approval clinical trials.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Phase</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Short Title" nciodm:ExtCodeID="C218676">
                    <ich:ICHDefinition>The short descriptive name for the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Short Title</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Version Date" nciodm:ExtCodeID="C93813">
                    <ich:ICHDefinition>The date on which the document is versioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Document Version Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Version Number" nciodm:ExtCodeID="C181232">
                    <ich:ICHDefinition>A string of alphanumeric characters that uniquely identifies a specific version of a study protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Protocol Version Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="WHO/UTN Number" nciodm:ExtCodeID="C218689">
                    <ich:ICHSynonym>Universal Trial Number</ich:ICHSynonym>
                    <ich:ICHDefinition>A sequence of characters used to identify a clinical trial, as assigned by the World Health Organisation&apos;s International Clinical Trial&apos;s Registry Platform (ICTRP).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>WHO/UTN Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>ICH M11 Section Title Page Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>ICH M11 Section Title Page Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section Title Page Data Element Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217282.Independent Committee Name Response Terminology" Name="Independent Committee Name Response Terminology" DataType="text" nciodm:ExtCodeID="C217282">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the independent committee name responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Dose Escalation Committee" nciodm:ExtCodeID="C215671">
                    <ich:ICHDefinition>A type of safety monitoring committee that monitors dose escalation activities in first-in-human trials.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Dose Escalation Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Endpoint Adjudication Committee" nciodm:ExtCodeID="C78726">
                    <ich:ICHDefinition>An external committee whose purpose is to evaluate study data and decide whether a study endpoint or other criterion has been met.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Adjudication Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Independent Data Monitoring Committee" nciodm:ExtCodeID="C142578">
                    <ich:ICHDefinition>A committee established by the sponsor to assess at intervals the progress of a clinical trial, safety data, and critical efficacy variables and recommend to the sponsor whether to continue, modify, or terminate the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Independent Data Monitoring Committee</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="None" nciodm:ExtCodeID="C41132">
                    <ich:ICHDefinition>No person or thing, nobody, not any.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>None</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other" nciodm:ExtCodeID="C17649">
                    <ich:ICHSynonym>Other</ich:ICHSynonym>
                    <ich:ICHDefinition>Different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Independent Committee Name Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Independent Committee Name Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Independent Committee Name Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217277.Intervention Model Response Terminology" Name="Intervention Model Response Terminology" DataType="text" nciodm:ExtCodeID="C217277">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the intervention model responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Cross-over" nciodm:ExtCodeID="C82637">
                    <ich:ICHDefinition>Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Crossover Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Factorial" nciodm:ExtCodeID="C82638">
                    <ich:ICHDefinition>Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Factorial Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other" nciodm:ExtCodeID="C17649">
                    <ich:ICHSynonym>Other</ich:ICHSynonym>
                    <ich:ICHDefinition>Different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Parallel Group" nciodm:ExtCodeID="C82639">
                    <ich:ICHDefinition>Participants are assigned to one of two or more treatment groups in parallel for the duration of the study.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Parallel Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sequential" nciodm:ExtCodeID="C142568">
                    <ich:ICHDefinition>Groups of participants are assigned to receive interventions based on prior milestones being reached in the study.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Group Sequential Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Single Group" nciodm:ExtCodeID="C82640">
                    <ich:ICHDefinition>All trial participants are assigned to a single treatment group for the duration of the study.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Single Group Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Intervention Model Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Intervention Model Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Intervention Model Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217284.Intervention Type Response Terminology" Name="Intervention Type Response Terminology" DataType="text" nciodm:ExtCodeID="C217284">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the intervention type responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Behavioral" nciodm:ExtCodeID="C15184">
                    <ich:ICHDefinition>A technique used to change the behavior of a participant (e.g., psychotherapy, lifestyle counseling, or hypnosis).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Behavioral Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Biologic" nciodm:ExtCodeID="C307">
                    <ich:ICHDefinition>A product of biological origin applicable to the prevention, treatment, or cure of a disease or condition, for example: virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Biological Agent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Combination Product" nciodm:ExtCodeID="C54696">
                    <ich:ICHDefinition>A product composed of two or more different types of medical products (i.e., a combination of a drug, device, and/or biological product with one another and are referred to as &quot;constituent parts&quot; of the combination product). (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Combination Product</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Device" nciodm:ExtCodeID="C16830">
                    <ich:ICHSynonym>Medical Device</ich:ICHSynonym>
                    <ich:ICHDefinition>Any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination for, one or more specific medical purpose(s). (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Medical Device</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Diagnostic Test" nciodm:ExtCodeID="C18020">
                    <ich:ICHDefinition>Any procedure or test to diagnose a disease or disorder.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Diagnostic Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Dietary Supplement" nciodm:ExtCodeID="C1505">
                    <ich:ICHDefinition>Preparations containing ingredient(s) intended to supplement the diet.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Dietary Supplement</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Drug" nciodm:ExtCodeID="C1909">
                    <ich:ICHDefinition>An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Pharmacologic Substance</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Genetic" nciodm:ExtCodeID="C15238">
                    <ich:ICHSynonym>Gene Therapy</ich:ICHSynonym>
                    <ich:ICHDefinition>Introduction of genetic material into cells in order to correct or treat an inherited or acquired disease.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Gene Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Non-Surgical Procedure" nciodm:ExtCodeID="C218507">
                    <ich:ICHDefinition>A medical procedure that produces an effect, or that is intended to alter the course of a disease in a patient or population, which is not considered a surgical procedure.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Non-Surgical Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Radiation" nciodm:ExtCodeID="C15313">
                    <ich:ICHSynonym>Radiation Therapy</ich:ICHSynonym>
                    <ich:ICHSynonym>Radiotherapy</ich:ICHSynonym>
                    <ich:ICHDefinition>Use of targeted or whole body radiation to treat a disease.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Radiation Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Surgery" nciodm:ExtCodeID="C15329">
                    <ich:ICHDefinition>A diagnostic or treatment procedure performed by manual and/or instrumental means, often involving an incision and the removal or replacement of a diseased organ or tissue; of or relating to or involving or used in surgery or requiring or amenable to treatment by surgery.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Surgical Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Vaccine" nciodm:ExtCodeID="C923">
                    <ich:ICHDefinition>A medicinal product inducing immunity against disease, most often to prevent occurrence of a disease, (e.g., a preventative vaccine against infectious disease), but also to treat a disease, (e.g., a therapeutic vaccine against cancer). (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Vaccine</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Intervention Type Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Intervention Type Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Intervention Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217285.Intervention Use Response Terminology" Name="Intervention Use Response Terminology" DataType="text" nciodm:ExtCodeID="C217285">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the intervention use responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Additional Required Treatment" nciodm:ExtCodeID="C207614">
                    <ich:ICHDefinition>A medicinal product that must be administered along with the experimental treatment (e.g., drug studies wherein opioid blockers are administered to prevent overdose).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Additional Required Medicinal Product</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Background Treatment" nciodm:ExtCodeID="C165822">
                    <ich:ICHDefinition>Medicinal products that are administered to each clinical trial participant, regardless of randomization group, a) to treat the indication which is the object of the study, or b) required in the protocol as part of standard care for a condition that is not the indication under investigation, and is relevant for the clinical trial design. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Background Treatment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Challenge Agent" nciodm:ExtCodeID="C158128">
                    <ich:ICHDefinition>A non-investigational medicinal product (NIMP) given to trial participants to produce a physiological response that is necessary before the pharmacological action of the investigational medicinal product can be assessed. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Challenge Agent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Diagnostic" nciodm:ExtCodeID="C18020">
                    <ich:ICHDefinition>Any procedure or test to diagnose a disease or disorder.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Diagnostic Procedure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Experimental Intervention" nciodm:ExtCodeID="C41161">
                    <ich:ICHDefinition>The drug, device, therapy, procedure, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Agent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Placebo" nciodm:ExtCodeID="C753">
                    <ich:ICHDefinition>A pharmaceutical preparation that does not contain the investigational agent and is generally prepared to be physically indistinguishable from the preparation containing the investigational product.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Placebo</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Rescue Medicine" nciodm:ExtCodeID="C165835">
                    <ich:ICHDefinition>Medicinal products identified in the protocol as those that may be administered to participants when the efficacy of the investigational medicinal product (IMP) is not satisfactory, the effect of the IMP is too great and is likely to cause a hazard to the patient, or to manage an emergency situation. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Rescue Medications</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Intervention Use Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Intervention Use Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Intervention Use Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217052.Investigational Intervention Sourcing Response Terminology" Name="Investigational Intervention Sourcing Response Terminology" DataType="text" nciodm:ExtCodeID="C217052">
                <Description>
                    <TranslatedText xml:lang="en">Terminology associated with the sourcing value set codelist of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Centrally Sourced" nciodm:ExtCodeID="C215659">
                    <ich:ICHDefinition>An indication that the entity is obtained from a central source.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Centrally Sourced Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Locally Sourced" nciodm:ExtCodeID="C215660">
                    <ich:ICHDefinition>An indication that the entity is obtained from a local source.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Locally Sourced Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Investigational Intervention Sourcing Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Investigational Intervention Sourcing Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Sourcing Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217286.Investigational Medicinal Product Indicator Response Terminology" Name="Investigational Medicinal Product Indicator Response Terminology" DataType="text" nciodm:ExtCodeID="C217286">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the investigational medicinal product indicator responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="IMP" nciodm:ExtCodeID="C202579">
                    <ich:ICHDefinition>A medicinal product which is being tested or used as a reference, including as a placebo, in a clinical trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigational Medicinal Product</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="NIMP" nciodm:ExtCodeID="C156473">
                    <ich:ICHDefinition>A medicinal product that is related to the specific needs of the clinical trial as described in the protocol, but not as an investigational medicinal product. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Auxiliary Medicinal Product</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Investigational Medicinal Product Indicator Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Investigational Medicinal Product Indicator Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Investigational Medicinal Product Indicator Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217046.No Yes Response Terminology" Name="No Yes Response Terminology" DataType="text" nciodm:ExtCodeID="C217046">
                <Description>
                    <TranslatedText xml:lang="en">Terminology associated with the no yes value set codelist of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="No" nciodm:ExtCodeID="C49487">
                    <ich:ICHSynonym>N</ich:ICHSynonym>
                    <ich:ICHDefinition>The non-affirmative response to a question.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>No</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Yes" nciodm:ExtCodeID="C49488">
                    <ich:ICHSynonym>Y</ich:ICHSynonym>
                    <ich:ICHDefinition>The affirmative response to a question.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Yes</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>No Yes Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>No Yes Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 No Yes Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217278.Population Type Response Terminology" Name="Population Type Response Terminology" DataType="text" nciodm:ExtCodeID="C217278">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the population type responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="With Disease" nciodm:ExtCodeID="C218503">
                    <ich:ICHDefinition>An indication that the individual or group of individuals has been diagnosed with the disease of interest or under study.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>With Disease</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Without Disease" nciodm:ExtCodeID="C218504">
                    <ich:ICHDefinition>An indication that the individual or group of individuals has not been diagnosed with the disease of interest or under study.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Without Disease</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Population Type Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Population Type Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Population Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217272.Protocol Section Name and Number Response Terminology" Name="Protocol Section Name and Number Response Terminology" DataType="text" nciodm:ExtCodeID="C217272">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the protocol section name and number responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="1 PROTOCOL SUMMARY" nciodm:ExtCodeID="C218514">
                    <ich:ICHDefinition>Section 1 of the ICH M11 Protocol standard, PROTOCOL SUMMARY.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 1 PROTOCOL SUMMARY</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="1.1 Protocol Synopsis" nciodm:ExtCodeID="C218515">
                    <ich:ICHDefinition>Section 1.1 of the ICH M11 Protocol standard, Protocol Synopsis.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 1.1 Protocol Synopsis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="1.1.1 Primary and Secondary Objectives and Estimands" nciodm:ExtCodeID="C218516">
                    <ich:ICHDefinition>Section 1.1.1 of the ICH M11 Protocol standard, Primary and Secondary Objectives and Estimands.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 1.1.1 Primary and Secondary Objectives and Estimands</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="1.1.2 Overall Design" nciodm:ExtCodeID="C218517">
                    <ich:ICHDefinition>Section 1.1.2 of the ICH M11 Protocol standard, Overall Design.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 1.1.2 Overall Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="1.2 Trial Schema" nciodm:ExtCodeID="C218518">
                    <ich:ICHDefinition>Section 1.2 of the ICH M11 Protocol standard, Trial Schema.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 1.2 Trial Schema</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="1.3 Schedule of Activities" nciodm:ExtCodeID="C218519">
                    <ich:ICHDefinition>Section 1.3 of the ICH M11 Protocol standard, Schedule of Activities.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 1.3 Schedule of Activities</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10 STATISTICAL CONSIDERATIONS" nciodm:ExtCodeID="C218625">
                    <ich:ICHDefinition>Section 10 of the ICH M11 Protocol standard, STATISTICAL CONSIDERATIONS.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10 STATISTICAL CONSIDERATIONS</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.1 General Considerations" nciodm:ExtCodeID="C218626">
                    <ich:ICHDefinition>Section 10.1 of the ICH M11 Protocol standard, General Considerations.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.1 General Considerations</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.10 Multiplicity Adjustments" nciodm:ExtCodeID="C218647">
                    <ich:ICHDefinition>Section 10.10 of the ICH M11 Protocol standard, Multiplicity Adjustments.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.10 Multiplicity Adjustments</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.11 Sample Size Determination" nciodm:ExtCodeID="C218648">
                    <ich:ICHDefinition>Section 10.11 of the ICH M11 Protocol standard, Sample Size Determination.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.11 Sample Size Determination</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.2 Analysis Sets" nciodm:ExtCodeID="C218627">
                    <ich:ICHDefinition>Section 10.2 of the ICH M11 Protocol standard, Analysis Sets.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.2 Analysis Sets</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.3 Analyses of Demographics and Other Baseline Variables" nciodm:ExtCodeID="C218628">
                    <ich:ICHDefinition>Section 10.3 of the ICH M11 Protocol standard, Analyses of Demographics and Other Baseline Variables.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.3 Analyses of Demographics and Other Baseline Variables</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.4 Analyses Associated with the Primary Objective(s)" nciodm:ExtCodeID="C218629">
                    <ich:ICHDefinition>Section 10.4 of the ICH M11 Protocol standard, Analyses Associated with the Primary Objective(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.4 Analyses Associated with the Primary Objective(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.4.1 Primary Objective" nciodm:ExtCodeID="C218630">
                    <ich:ICHDefinition>Section 10.4.1 of the ICH M11 Protocol standard, Primary Objective.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.4.1 Primary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.4.1.1 Statistical Analysis Method" nciodm:ExtCodeID="C218631">
                    <ich:ICHDefinition>Section 10.4.1.1 of the ICH M11 Protocol standard, Statistical Analysis Method.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.4.1.1 Statistical Analysis Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.4.1.2 Handling of Data in Relation to Primary Estimand(s)" nciodm:ExtCodeID="C218632">
                    <ich:ICHDefinition>Section 10.4.1.2 of the ICH M11 Protocol standard, Handling of Data in Relation to Primary Estimand(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.4.1.2 Handling of Data in Relation to Primary Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.4.1.3 Handling of Missing Data in Relation to Primary Estimand(s)" nciodm:ExtCodeID="C218633">
                    <ich:ICHDefinition>Section 10.4.1.3 of the ICH M11 Protocol standard, Handling of Missing Data in Relation to Primary Estimand(s)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.4.1.3 Handling of Missing Data in Relation to Primary Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.4.1.4 Sensitivity Analysis" nciodm:ExtCodeID="C218634">
                    <ich:ICHDefinition>Section 10.4.1.4 of the ICH M11 Protocol standard, Sensitivity Analysis.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.4.1.4 Sensitivity Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.4.1.5 Supplementary Analysis" nciodm:ExtCodeID="C218635">
                    <ich:ICHDefinition>Section 10.4.1.5 of the ICH M11 Protocol standard, Supplementary Analysis.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.4.1.5 Supplementary Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.5 Analyses Associated with the Secondary Objective(s)" nciodm:ExtCodeID="C218636">
                    <ich:ICHDefinition>Section 10.5 of the ICH M11 Protocol standard, Analyses Associated with the Secondary Objective(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.5 Analyses Associated with the Secondary Objective(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.5.1 Secondary Objective" nciodm:ExtCodeID="C218637">
                    <ich:ICHDefinition>Section 10.5.1 of the ICH M11 Protocol standard, Secondary Objective.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.5.1 Secondary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.5.1.1 Statistical Analysis Method" nciodm:ExtCodeID="C218638">
                    <ich:ICHDefinition>Section 10.5.1.1 of the ICH M11 Protocol standard, Statistical Analysis Method.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.5.1.1 Statistical Analysis Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.5.1.2 Handling of Data in Relation to Secondary Estimand(s)" nciodm:ExtCodeID="C218639">
                    <ich:ICHDefinition>Section 10.5.1.2 of the ICH M11 Protocol standard, Handling of Data in Relation to Secondary Estimand(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.5.1.2 Handling of Data in Relation to Secondary Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.5.1.3 Handling of Missing Data in Relation to Secondary Estimand(s)" nciodm:ExtCodeID="C218640">
                    <ich:ICHDefinition>Section 10.5.1.3 of the ICH M11 Protocol standard, Handling of Missing Data in Relation to Secondary Estimand(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.5.1.3 Handling of Missing Data in Relation to Secondary Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.5.1.4 Sensitivity Analysis" nciodm:ExtCodeID="C218641">
                    <ich:ICHDefinition>Section 10.5.1.4 of the ICH M11 Protocol standard, Sensitivity Analysis.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.5.1.4 Sensitivity Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.5.1.5 Supplementary Analysis" nciodm:ExtCodeID="C218642">
                    <ich:ICHDefinition>Section 10.5.1.5 of the ICH M11 Protocol standard, Supplementary Analysis.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.5.1.5 Supplementary Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.6 Analyses Associated with the Exploratory Objective(s)" nciodm:ExtCodeID="C218643">
                    <ich:ICHDefinition>Section 10.6 of the ICH M11 Protocol standard, Analyses Associated with the Exploratory Objective(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.6 Analyses Associated with the Exploratory Objective(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.7 Safety Analyses" nciodm:ExtCodeID="C218644">
                    <ich:ICHDefinition>Section 10.7 of the ICH M11 Protocol standard, Safety Analyses.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.7 Safety Analyses</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.8 Other Analyses" nciodm:ExtCodeID="C218645">
                    <ich:ICHDefinition>Section 10.8 of the ICH M11 Protocol standard, Other Analyses.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.8 Other Analyses</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="10.9 Interim Analyses" nciodm:ExtCodeID="C218646">
                    <ich:ICHDefinition>Section 10.9 of the ICH M11 Protocol standard, Interim Analyses.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 10.9 Interim Analyses</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11 TRIAL OVERSIGHT AND OTHER GENERAL CONSIDERATIONS" nciodm:ExtCodeID="C218649">
                    <ich:ICHDefinition>Section 11 of the ICH M11 Protocol standard, TRIAL OVERSIGHT AND OTHER GENERAL CONSIDERATIONS.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11 TRIAL OVERSIGHT AND OTHER GENERAL CONSIDERATIONS</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.1 Regulatory and Ethical Considerations" nciodm:ExtCodeID="C218650">
                    <ich:ICHDefinition>Section 11.1 of the ICH M11 Protocol standard, Regulatory and Ethical Considerations.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.1 Regulatory and Ethical Considerations</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.10 Protocol Deviations" nciodm:ExtCodeID="C218663">
                    <ich:ICHDefinition>Section 11.10 of the ICH M11 Protocol standard, Protocol Deviations.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.10 Protocol Deviations</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.11 Early Site Closure" nciodm:ExtCodeID="C218664">
                    <ich:ICHDefinition>Section 11.11 of the ICH M11 Protocol standard, Early Site Closure.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.11 Early Site Closure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.12 Data Dissemination" nciodm:ExtCodeID="C218665">
                    <ich:ICHDefinition>Section 11.12 of the ICH M11 Protocol standard, Data Dissemination.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.12 Data Dissemination</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.2 Trial Oversight" nciodm:ExtCodeID="C218651">
                    <ich:ICHDefinition>Section 11.2 of the ICH M11 Protocol standard, Trial Oversight.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.2 Trial Oversight</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.2.1 Investigator Responsibilities" nciodm:ExtCodeID="C218652">
                    <ich:ICHDefinition>Section 11.2.1 of the ICH M11 Protocol standard, Investigator Responsibilities.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.2.1 Investigator Responsibilities</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.2.2 Sponsor Responsibilities" nciodm:ExtCodeID="C218653">
                    <ich:ICHDefinition>Section 11.2.2 of the ICH M11 Protocol standard, Sponsor Responsibilities.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.2.2 Sponsor Responsibilities</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.3 Informed Consent Process" nciodm:ExtCodeID="C218654">
                    <ich:ICHDefinition>Section 11.3 of the ICH M11 Protocol standard, Informed Consent Process.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.3 Informed Consent Process</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.3.1 Informed Consent for Rescreening" nciodm:ExtCodeID="C218655">
                    <ich:ICHDefinition>Section 11.3.1 of the ICH M11 Protocol standard, Informed Consent for Rescreening.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.3.1 Informed Consent for Rescreening</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.3.2 Informed Consent for Use of Remaining Samples in Exploratory Research" nciodm:ExtCodeID="C218656">
                    <ich:ICHDefinition>Section 11.3.2 of the ICH M11 Protocol standard, Informed Consent for Use of Remaining Samples in Exploratory Research.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.3.2 Informed Consent for Use of Remaining Samples in Exploratory Research</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.4 Committees" nciodm:ExtCodeID="C218657">
                    <ich:ICHDefinition>Section 11.4 of the ICH M11 Protocol standard, Committees.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.4 Committees</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.5 Insurance and Indemnity" nciodm:ExtCodeID="C218658">
                    <ich:ICHDefinition>Section 11.5 of the ICH M11 Protocol standard, Insurance and Indemnity.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.5 Insurance and Indemnity</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.6 Risk-Based Quality Management" nciodm:ExtCodeID="C218659">
                    <ich:ICHDefinition>Section 11.6 of the ICH M11 Protocol standard, Risk-Based Quality Management.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.6 Risk-Based Quality Management</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.7 Data Governance" nciodm:ExtCodeID="C218660">
                    <ich:ICHDefinition>Section 11.7 of the ICH M11 Protocol standard, Data Governance.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.7 Data Governance</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.8 Data Protection" nciodm:ExtCodeID="C218661">
                    <ich:ICHDefinition>Section 11.8 of the ICH M11 Protocol standard, Data Protection.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.8 Data Protection</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="11.9 Source Data" nciodm:ExtCodeID="C218662">
                    <ich:ICHDefinition>Section 11.9 of the ICH M11 Protocol standard, Source Data.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 11.9 Source Data</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="12 APPENDIX: SUPPORTING DETAILS" nciodm:ExtCodeID="C218666">
                    <ich:ICHDefinition>Section 12 of the ICH M11 Protocol standard, APPENDIX: SUPPORTING DETAILS.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 12 APPENDIX: SUPPORTING DETAILS</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="12.1 Clinical Laboratory Tests" nciodm:ExtCodeID="C218667">
                    <ich:ICHDefinition>Section 12.1 of the ICH M11 Protocol standard, Clinical Laboratory Tests.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 12.1 Clinical Laboratory Tests</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="12.2 Country/Region-Specific Differences" nciodm:ExtCodeID="C218668">
                    <ich:ICHDefinition>Section 12.2 of the ICH M11 Protocol standard, Country/Region-Specific Differences.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 12.2 Country/Region-Specific Differences</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="12.3 Prior Protocol Amendment(s)" nciodm:ExtCodeID="C218669">
                    <ich:ICHDefinition>Section 12.3 of the ICH M11 Protocol standard, Prior Protocol Amendment(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 12.3 Prior Protocol Amendment(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="13 APPENDIX: GLOSSARY OF TERMS AND ABBREVIATIONS" nciodm:ExtCodeID="C218670">
                    <ich:ICHDefinition>Section 13 of the ICH M11 Protocol standard, APPENDIX: GLOSSARY OF TERMS AND ABBREVIATIONS.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 13 APPENDIX: GLOSSARY OF TERMS AND ABBREVIATIONS</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="14 APPENDIX: REFERENCES" nciodm:ExtCodeID="C218671">
                    <ich:ICHDefinition>Section 14 of the ICH M11 Protocol standard, APPENDIX: REFERENCES.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 14 APPENDIX: REFERENCES</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="2 INTRODUCTION" nciodm:ExtCodeID="C218520">
                    <ich:ICHDefinition>Section 2 of the ICH M11 Protocol standard, INTRODUCTION.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 2 INTRODUCTION</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="2.1 Purpose of Trial" nciodm:ExtCodeID="C218521">
                    <ich:ICHDefinition>Section 2.1 of the ICH M11 Protocol standard, Purpose of Trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 2.1 Purpose of Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="2.2 Assessment of Risks and Benefits" nciodm:ExtCodeID="C218522">
                    <ich:ICHDefinition>Section 2.2 of the ICH M11 Protocol standard, Assessment of Risks and Benefits.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 2.2 Assessment of Risks and Benefits</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="2.2.1 Risk Summary and Mitigation Strategy" nciodm:ExtCodeID="C218523">
                    <ich:ICHDefinition>Section 2.2.2 of the ICH M11 Protocol standard, Risk Summary and Mitigation Strategy.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 2.2.1 Risk Summary and Mitigation Strategy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="2.2.2 Benefit Summary" nciodm:ExtCodeID="C218524">
                    <ich:ICHDefinition>Section 2.2.1 of the ICH M11 Protocol standard, Benefit Summary.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 2.2.2 Benefit Summary</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="2.2.3 Overall Risk-Benefit Assessment" nciodm:ExtCodeID="C218525">
                    <ich:ICHDefinition>Section 2.2.3 of the ICH M11 Protocol standard, Overall Risk-Benefit Assessment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 2.2.3 Overall Risk-Benefit Assessment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="3 TRIAL OBJECTIVES AND ASSOCIATED ESTIMANDS" nciodm:ExtCodeID="C218526">
                    <ich:ICHDefinition>Section 3 of the ICH M11 Protocol standard, TRIAL OBJECTIVES AND ASSOCIATED ESTIMANDS.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 3 TRIAL OBJECTIVES AND ASSOCIATED ESTIMANDS</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="3.1 Primary Objective(s) and Associated Estimand(s)" nciodm:ExtCodeID="C218527">
                    <ich:ICHDefinition>Section 3.1 of the ICH M11 Protocol standard, Primary Objective(s) and Associated Estimand(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 3.1 Primary Objective(s) and Associated Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="3.1.1 Primary Objective" nciodm:ExtCodeID="C218528">
                    <ich:ICHDefinition>Section 3.1.1 of the ICH M11 Protocol standard, Primary Objective.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 3.1.1 Primary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="3.2 Secondary Objective(s) and Associated Estimand(s)" nciodm:ExtCodeID="C218529">
                    <ich:ICHDefinition>Section 3.2 of the ICH M11 Protocol standard, Secondary Objective(s) and Associated Estimand(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 3.2 Secondary Objective(s) and Associated Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="3.2.1 Secondary Objective" nciodm:ExtCodeID="C218530">
                    <ich:ICHDefinition>Section 3.2.1 of the ICH M11 Protocol standard, Secondary Objective.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 3.2.1 Secondary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="3.3 Exploratory Objective(s)" nciodm:ExtCodeID="C218531">
                    <ich:ICHDefinition>Section 3.3 of the ICH M11 Protocol standard, Exploratory Objective(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 3.3 Exploratory Objective(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="3.3.1 Exploratory Objective" nciodm:ExtCodeID="C218532">
                    <ich:ICHDefinition>Section 3.3.1 of the ICH M11 Protocol standard, Exploratory Objective.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 3.3.1 Exploratory Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4 TRIAL DESIGN" nciodm:ExtCodeID="C218533">
                    <ich:ICHDefinition>Section 4 of the ICH M11 Protocol standard, TRIAL DESIGN.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4 TRIAL DESIGN</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.1 Description of Trial Design" nciodm:ExtCodeID="C218534">
                    <ich:ICHDefinition>Section 4.1 of the ICH M11 Protocol standard, Description of Trial Design.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.1 Description of Trial Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.1.1 Stakeholder Input into Design" nciodm:ExtCodeID="C218535">
                    <ich:ICHDefinition>Section 4.1.1 of the ICH M11 Protocol standard, Stakeholder Input into Design.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.1.1 Stakeholder Input into Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.2 Rationale for Trial Design" nciodm:ExtCodeID="C218536">
                    <ich:ICHDefinition>Section 4.2 of the ICH M11 Protocol standard, Rationale for Trial Design.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.2 Rationale for Trial Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.2.1 Rationale for Estimand(s)" nciodm:ExtCodeID="C218537">
                    <ich:ICHDefinition>Section 4.2.1 of the ICH M11 Protocol standard, Rationale for Estimand(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.2.1 Rationale for Estimand(s)</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.2.2 Rationale for Intervention Model" nciodm:ExtCodeID="C218538">
                    <ich:ICHDefinition>Section 4.2.2 of the ICH M11 Protocol standard, Rationale for Intervention Model.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.2.2 Rationale for Intervention Model</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.2.3 Rationale for Control Type" nciodm:ExtCodeID="C218539">
                    <ich:ICHDefinition>Section 4.2.3 of the ICH M11 Protocol standard, Rationale for Control Type.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.2.3 Rationale for Control Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.2.4 Rationale for Trial Duration" nciodm:ExtCodeID="C218540">
                    <ich:ICHDefinition>Section 4.2.4 of the ICH M11 Protocol standard, Rationale for Trial Duration.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.2.4 Rationale for Trial Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.2.5 Rationale for Adaptive or Novel Trial Design" nciodm:ExtCodeID="C218541">
                    <ich:ICHDefinition>Section 4.2.5 of the ICH M11 Protocol standard, Rationale for Adaptive or Novel Trial Design.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.2.5 Rationale for Adaptive or Novel Trial Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.2.6 Rationale for Interim Analysis" nciodm:ExtCodeID="C218542">
                    <ich:ICHDefinition>Section 4.2.6 of the ICH M11 Protocol standard, Rationale for Interim Analysis.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.2.6 Rationale for Interim Analysis</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.2.7 Rationale for Other Trial Design Aspects" nciodm:ExtCodeID="C218543">
                    <ich:ICHDefinition>Section 4.2.7 of the ICH M11 Protocol standard, Rationale for Other Trial Design Aspects.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.2.7 Rationale for Other Trial Design Aspects</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.3 Trial Stopping Rules" nciodm:ExtCodeID="C218544">
                    <ich:ICHDefinition>Section 4.3 of the ICH M11 Protocol standard, Trial Stopping Rules.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.3 Trial Stopping Rules</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.4 Start of Trial and End of Trial" nciodm:ExtCodeID="C218545">
                    <ich:ICHDefinition>Section 4.4 of the ICH M11 Protocol standard, Start of Trial and End of Trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.4 Start of Trial and End of Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="4.5 Access to Trial Intervention After End of Trial" nciodm:ExtCodeID="C218546">
                    <ich:ICHDefinition>Section 4.5 of the ICH M11 Protocol standard, Access to Trial Intervention After End of Trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 4.5 Access to Trial Intervention After End of Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5 TRIAL POPULATION" nciodm:ExtCodeID="C218547">
                    <ich:ICHDefinition>Section 5 of the ICH M11 Protocol standard, TRIAL POPULATION.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5 TRIAL POPULATION</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.1 Description of Trial Population and Rationale" nciodm:ExtCodeID="C218548">
                    <ich:ICHDefinition>Section 5.1 of the ICH M11 Protocol standard, Description of Trial Population and Rationale.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.1 Description of Trial Population and Rationale</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.2 Inclusion Criteria" nciodm:ExtCodeID="C218549">
                    <ich:ICHDefinition>Section 5.2 of the ICH M11 Protocol standard, Inclusion Criteria.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.2 Inclusion Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.3 Exclusion Criteria" nciodm:ExtCodeID="C218550">
                    <ich:ICHDefinition>Section 5.3 of the ICH M11 Protocol standard, Exclusion Criteria.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.3 Exclusion Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.4 Contraception" nciodm:ExtCodeID="C218551">
                    <ich:ICHDefinition>Section 5.4 of the ICH M11 Protocol standard, Contraception.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.4 Contraception</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.4.1 Definitions Related to Childbearing Potential" nciodm:ExtCodeID="C218552">
                    <ich:ICHDefinition>Section 5.4.1 of the ICH M11 Protocol standard, Definitions Related to Childbearing Potential.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.4.1 Definitions Related to Childbearing Potential</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.4.2 Contraception Requirements" nciodm:ExtCodeID="C218553">
                    <ich:ICHDefinition>Section 5.4.2 of the ICH M11 Protocol standard, Contraception Requirements.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.4.2 Contraception Requirements</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.5 Lifestyle Restrictions" nciodm:ExtCodeID="C218554">
                    <ich:ICHDefinition>Section 5.5 of the ICH M11 Protocol standard, Lifestyle Restrictions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.5 Lifestyle Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.5.1 Meals and Dietary Restrictions" nciodm:ExtCodeID="C218555">
                    <ich:ICHDefinition>Section 5.5.1 of the ICH M11 Protocol standard, Meals and Dietary Restrictions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.5.1 Meals and Dietary Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.5.2 Caffeine, Alcohol, Tobacco, and Other Restrictions" nciodm:ExtCodeID="C218556">
                    <ich:ICHDefinition>Section 5.5.2 of the ICH M11 Protocol standard, Caffeine, Alcohol, Tobacco, and Other Restrictions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.5.2 Caffeine, Alcohol, Tobacco, and Other Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.5.3 Physical Activity Restrictions" nciodm:ExtCodeID="C218557">
                    <ich:ICHDefinition>Section 5.5.3 of the ICH M11 Protocol standard, Physical Activity Restrictions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.5.3 Physical Activity Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.5.4 Other Activity Restrictions" nciodm:ExtCodeID="C218558">
                    <ich:ICHDefinition>Section 5.5.4 of the ICH M11 Protocol standard, Other Activity Restrictions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.5.4 Other Activity Restrictions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="5.6 Screen Failure and Rescreening" nciodm:ExtCodeID="C218559">
                    <ich:ICHDefinition>Section 5.6 of the ICH M11 Protocol standard, Screen Failure and Rescreening.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 5.6 Screen Failure and Rescreening</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6 TRIAL INTERVENTION AND CONCOMITANT THERAPY" nciodm:ExtCodeID="C218560">
                    <ich:ICHDefinition>Section 6 of the ICH M11 Protocol standard, TRIAL INTERVENTION AND CONCOMITANT THERAPY.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6 TRIAL INTERVENTION AND CONCOMITANT THERAPY</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.1 Description of Investigational Trial Intervention" nciodm:ExtCodeID="C218561">
                    <ich:ICHDefinition>Section 6.1 of the ICH M11 Protocol standard, Description of Investigational Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.1 Description of Investigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.10 Concomitant Therapy" nciodm:ExtCodeID="C218580">
                    <ich:ICHDefinition>Section 6.10 of the ICH M10 Protocol standard, Concomitant Therapy.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.10 Concomitant Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.10.1 Prohibited Concomitant Therapy" nciodm:ExtCodeID="C218581">
                    <ich:ICHDefinition>Section 6.10.1 of the ICH M10 Protocol standard, Prohibited Concomitant Therapy.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.10.1 Prohibited Concomitant Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.10.2 Permitted Concomitant Therapy" nciodm:ExtCodeID="C218582">
                    <ich:ICHDefinition>Section 6.10.2 of the ICH M10 Protocol standard, Permitted Concomitant Therapy.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.10.2 Permitted Concomitant Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.2 Rationale for Investigational Trial Intervention Dose and Regimen" nciodm:ExtCodeID="C218562">
                    <ich:ICHDefinition>Section 6.2 of the ICH M11 Protocol standard, Rationale for Investigational Trial Intervention Dose and Regimen.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.2 Rationale for Investigational Trial Intervention Dose and Regimen</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.3 Investigational Trial Intervention Administration" nciodm:ExtCodeID="C218563">
                    <ich:ICHDefinition>Section 6.3 of the ICH M11 Protocol standard, Investigational Trial Intervention Administration.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.3 Investigational Trial Intervention Administration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.4 Investigational Trial Intervention Dose Modification" nciodm:ExtCodeID="C218564">
                    <ich:ICHDefinition>Section 6.4 of the ICH M11 Protocol standard, Investigational Trial Intervention Dose Modification.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.4 Investigational Trial Intervention Dose Modification</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.5 Management of Investigational Trial Intervention Overdose" nciodm:ExtCodeID="C218565">
                    <ich:ICHDefinition>Section 6.5 of the ICH M11 Protocol standard, Management of Investigational Trial Intervention Overdose.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.5 Management of Investigational Trial Intervention Overdose</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.6 Preparation, Storage, Handling and Accountability of Investigational Trial Intervention" nciodm:ExtCodeID="C218566">
                    <ich:ICHDefinition>Section 6.6 of the ICH M11 Protocol standard, Preparation, Storage, Handling and Accountability of Investigational Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.6 Preparation, Storage, Handling and Accountability of Investigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.6.1 Preparation of Investigational Trial Intervention" nciodm:ExtCodeID="C218567">
                    <ich:ICHDefinition>Section 6.6.1 of the ICH M11 Protocol standard, Preparation of Investigational Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.6.1 Preparation of Investigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.6.2 Storage and Handling of Investigational Trial Intervention" nciodm:ExtCodeID="C218568">
                    <ich:ICHDefinition>Section 6.6.2 of the ICH M11 Protocol standard, Storage and Handling of Investigational Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.6.2 Storage and Handling of Investigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.6.3 Accountability of Investigational Trial Intervention" nciodm:ExtCodeID="C218569">
                    <ich:ICHDefinition>Section 6.6.3 of the ICH M11 Protocol standard, Accountability of Investigational Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.6.3 Accountability of Investigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.7 Investigational Trial Intervention Assignment, Randomisation and Blinding" nciodm:ExtCodeID="C218570">
                    <ich:ICHDefinition>Section 6.7 of the ICH M11 Protocol standard, Investigational Trial Intervention Assignment, Randomisation and Blinding.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.7 Investigational Trial Intervention Assignment, Randomisation and Blinding</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.7.1 Participant Assignment to Investigational Trial Intervention" nciodm:ExtCodeID="C218571">
                    <ich:ICHDefinition>Section 6.7.1 of the ICH M11 Protocol standard, Participant Assignment to Investigational Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.7.1 Participant Assignment to Investigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.7.2 Randomisation" nciodm:ExtCodeID="C218572">
                    <ich:ICHDefinition>Section 6.7.2 of the ICH M11 Protocol standard, Randomisation.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.7.2 Randomisation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.7.3 Measures to Maintain Blinding" nciodm:ExtCodeID="C218573">
                    <ich:ICHDefinition>Section 6.7.3 of the ICH M11 Protocol standard, Measures to Maintain Blinding.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.7.3 Measures to Maintain Blinding</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.7.4 Emergency Unblinding at the Site" nciodm:ExtCodeID="C218574">
                    <ich:ICHDefinition>Section 6.7.4 of the ICH M11 Protocol standard, Emergency Unblinding at the Site.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.7.4 Emergency Unblinding at the Site</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.8 Investigational Trial Intervention Adherence" nciodm:ExtCodeID="C218575">
                    <ich:ICHDefinition>Section 6.8 of the ICH M11 Protocol standard, Investigational Trial Intervention Adherence.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.8 Investigational Trial Intervention Adherence</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.9 Description of Noninvestigational Trial Intervention" nciodm:ExtCodeID="C218576">
                    <ich:ICHDefinition>Section 6.9 of the ICH M11 Protocol standard, Description of Noninvestigational Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.9 Description of Noninvestigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.9.1 Background Trial Intervention" nciodm:ExtCodeID="C218577">
                    <ich:ICHDefinition>Section 6.9.1 of the ICH M11 Protocol standard, Background Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.9.1 Background Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.9.2 Rescue Therapy" nciodm:ExtCodeID="C218578">
                    <ich:ICHDefinition>Section 6.9.2 of the ICH M11 Protocol standard, Rescue Therapy.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.9.2 Rescue Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="6.9.3 Other Noninvestigational Trial Intervention" nciodm:ExtCodeID="C218579">
                    <ich:ICHDefinition>Section 6.9.3 of the ICH M11 Protocol standard, Other Noninvestigational Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 6.9.3 Other Noninvestigational Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="7 PARTICIPANT DISCONTINUATION OF TRIAL INTERVENTION AND DISCONTINUATION OR WITHDRAWAL FROM TRIAL" nciodm:ExtCodeID="C218583">
                    <ich:ICHDefinition>Section 7 of the ICH M11 Protocol standard, PARTICIPANT DISCONTINUATION OF TRIAL INTERVENTION AND DISCONTINUATION OR WITHDRAWAL FROM TRIAL.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 7 PARTICIPANT DISCONTINUATION OF TRIAL INTERVENTION AND DISCONTINUATION OR WITHDRAWAL FROM TRIAL</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="7.1 Discontinuation of Trial Intervention for Individual Participants" nciodm:ExtCodeID="C218584">
                    <ich:ICHDefinition>Section 7.1 of the ICH M11 Protocol standard, Discontinuation of Trial Intervention for Individual Participants.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 7.1 Discontinuation of Trial Intervention for Individual Participants</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="7.1.1 Permanent Discontinuation of Trial Intervention" nciodm:ExtCodeID="C218585">
                    <ich:ICHDefinition>Section 7.1.1 of the ICH M11 Protocol standard, Permanent Discontinuation of Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 7.1.1 Permanent Discontinuation of Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="7.1.2 Temporary Discontinuation of Trial Intervention" nciodm:ExtCodeID="C218586">
                    <ich:ICHDefinition>Section 7.1.2 of the ICH M11 Protocol standard, Temporary Discontinuation of Trial Intervention.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 7.1.2 Temporary Discontinuation of Trial Intervention</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="7.1.3 Rechallenge" nciodm:ExtCodeID="C218587">
                    <ich:ICHDefinition>Section 7.1.3 of the ICH M11 Protocol standard, Rechallenge.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 7.1.3 Rechallenge</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="7.2 Participant Discontinuation or Withdrawal from the Trial" nciodm:ExtCodeID="C218588">
                    <ich:ICHDefinition>Section 7.2 of the ICH M11 Protocol standard, Participant Discontinuation or Withdrawal from the Trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 7.2 Participant Discontinuation or Withdrawal from the Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="7.3 Management of Loss to Follow-Up" nciodm:ExtCodeID="C218589">
                    <ich:ICHDefinition>Section 7.3 of the ICH M11 Protocol standard, Management of Loss to Follow-Up.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 7.3 Management of Loss to Follow-Up</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8 TRIAL ASSESSMENTS AND PROCEDURES" nciodm:ExtCodeID="C218590">
                    <ich:ICHDefinition>Section 8 of the ICH M11 Protocol standard, TRIAL ASSESSMENTS AND PROCEDURES.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8 TRIAL ASSESSMENTS AND PROCEDURES</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.1 Trial Assessments and Procedures Considerations" nciodm:ExtCodeID="C218591">
                    <ich:ICHDefinition>Section 8.1 of the ICH M11 Protocol standard, Trial Assessments and Procedures Considerations.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.1 Trial Assessments and Procedures Considerations</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.2 Screening/Baseline Assessments and Procedures" nciodm:ExtCodeID="C218592">
                    <ich:ICHDefinition>Section 8.2 of the ICH M11 Protocol standard, Screening/Baseline Assessments and Procedures.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.2 Screening/Baseline Assessments and Procedures</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.3 Efficacy Assessments and Procedures" nciodm:ExtCodeID="C218593">
                    <ich:ICHDefinition>Section 8.3 of the ICH M11 Protocol standard, Efficacy Assessments and Procedures.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.3 Efficacy Assessments and Procedures</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.4 Safety Assessments and Procedures" nciodm:ExtCodeID="C218594">
                    <ich:ICHDefinition>Section 8.4 of the ICH M11 Protocol standard, Safety Assessments and Procedures.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.4 Safety Assessments and Procedures</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.4.1 Physical Examination" nciodm:ExtCodeID="C218595">
                    <ich:ICHDefinition>Section 8.4.1 of the ICH M11 Protocol standard, Physical Examination.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.4.1 Physical Examination</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.4.2 Vital Signs" nciodm:ExtCodeID="C218596">
                    <ich:ICHDefinition>Section 8.4.2 of the ICH M11 Protocol standard, Vital Signs.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.4.2 Vital Signs</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.4.3 Electrocardiograms" nciodm:ExtCodeID="C218597">
                    <ich:ICHDefinition>Section 8.4.3 of the ICH M11 Protocol standard, Electrocardiograms.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.4.3 Electrocardiograms</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.4.4 Clinical Laboratory Assessments" nciodm:ExtCodeID="C218598">
                    <ich:ICHDefinition>Section 8.4.4 of the ICH M11 Protocol standard, Clinical Laboratory Assessments.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.4.4 Clinical Laboratory Assessments</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.4.5 Pregnancy Testing" nciodm:ExtCodeID="C218599">
                    <ich:ICHDefinition>Section 8.4.5 of the ICH M11 Protocol standard, Pregnancy Testing.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.4.5 Pregnancy Testing</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.4.6 Suicidal Ideation and Behaviour Risk Monitoring" nciodm:ExtCodeID="C218600">
                    <ich:ICHDefinition>Section 8.4.6 of the ICH M11 Protocol standard, Suicidal Ideation and Behaviour Risk Monitoring.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.4.6 Suicidal Ideation and Behaviour Risk Monitoring</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.5 Pharmacokinetics" nciodm:ExtCodeID="C218601">
                    <ich:ICHDefinition>Section 8.5 of the ICH M11 Protocol standard, Pharmacokinetics.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.5 Pharmacokinetics</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.6 Biomarkers" nciodm:ExtCodeID="C218602">
                    <ich:ICHDefinition>Section 8.6 of the ICH M11 Protocol standard, Biomarkers.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.6 Biomarkers</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.6.1 Genetics and Pharmacogenomics" nciodm:ExtCodeID="C218603">
                    <ich:ICHDefinition>Section 8.6.1 of the ICH M11 Protocol standard, Genetics and Pharmacogenomics.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.6.1 Genetics and Pharmacogenomics</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.6.2 Pharmacodynamic Biomarkers" nciodm:ExtCodeID="C218604">
                    <ich:ICHDefinition>Section 8.6.2 of the ICH M11 Protocol standard, Pharmacodynamic Biomarkers.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.6.2 Pharmacodynamic Biomarkers</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.6.3 Other Biomarkers" nciodm:ExtCodeID="C218605">
                    <ich:ICHDefinition>Section 8.6.3 of the ICH M11 Protocol standard, Other Biomarkers.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.6.3 Other Biomarkers</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.7 Immunogenicity Assessments" nciodm:ExtCodeID="C218606">
                    <ich:ICHDefinition>Section 8.7 of the ICH M11 Protocol standard, Immunogenicity Assessments.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.7 Immunogenicity Assessments</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="8.8 Medical Resource Utilisation and Health Economics" nciodm:ExtCodeID="C218607">
                    <ich:ICHDefinition>Section 8.8 of the ICH M11 Protocol standard, Medical Resource Utilisation and Health Economics.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 8.8 Medical Resource Utilisation and Health Economics</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9 ADVERSE EVENTS, SERIOUS ADVERSE EVENTS, PRODUCT COMPLAINTS, PREGNANCY AND POSTPARTUM INFORMATION, AND SPECIAL SAFETY SITUATIONS" nciodm:ExtCodeID="C218608">
                    <ich:ICHDefinition>Section 9 of the ICH M11 Protocol standard, ADVERSE EVENTS, SERIOUS ADVERSE EVENTS, PRODUCT COMPLAINTS, PREGNANCY AND POSTPARTUM INFORMATION, AND SPECIAL SAFETY SITUATIONS.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9 ADVERSE EVENTS, SERIOUS ADVERSE EVENTS, PRODUCT COMPLAINTS, PREGNANCY AND POSTPARTUM INFORMATION, AND SPECIAL SAFETY SITUATIONS</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.1 Definitions" nciodm:ExtCodeID="C218609">
                    <ich:ICHDefinition>Section 9.1 of the ICH M11 Protocol standard, Definitions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.1 Definitions</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.1.1 Definitions of Adverse Events" nciodm:ExtCodeID="C218610">
                    <ich:ICHDefinition>Section 9.1.1 of the ICH M11 Protocol standard, Definitions of Adverse Events.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.1.1 Definitions of Adverse Events</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.1.2 Definitions of Serious Adverse Events" nciodm:ExtCodeID="C218611">
                    <ich:ICHDefinition>Section 9.1.2 of the ICH M11 Protocol standard, Definitions of Serious Adverse Events.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.1.2 Definitions of Serious Adverse Events</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.1.3 Definitions of Product Complaints" nciodm:ExtCodeID="C218612">
                    <ich:ICHDefinition>Section 9.1.3 of the ICH M11 Protocol standard, Definitions of Product Complaints.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.1.3 Definitions of Product Complaints</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.1.3.1 Definition of Medical Device Product Complaints" nciodm:ExtCodeID="C218613">
                    <ich:ICHDefinition>Section 9.1.3.1 of the ICH M11 Protocol standard, Definition of Medical Device Product Complaints.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.1.3.1 Definition of Medical Device Product Complaints</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.2 Timing and Procedures for Collection and Reporting" nciodm:ExtCodeID="C218614">
                    <ich:ICHDefinition>Section 9.2 of the ICH M11 Protocol standard, Timing and Procedures for Collection and Reporting.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.2 Timing and Procedures for Collection and Reporting</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.2.1 Timing" nciodm:ExtCodeID="C218615">
                    <ich:ICHDefinition>Section 9.2.1 of the ICH M11 Protocol standard, Timing.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.2.1 Timing</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.2.2 Collection Procedures" nciodm:ExtCodeID="C218616">
                    <ich:ICHDefinition>Section 9.2.2 of the ICH M11 Protocol standard, Collection Procedures.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.2.2 Collection Procedures</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.2.3 Reporting" nciodm:ExtCodeID="C218617">
                    <ich:ICHDefinition>Section 9.2.3 of the ICH M11 Protocol standard, Reporting.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.2.3 Reporting</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.2.3.1 Regulatory Reporting Requirements" nciodm:ExtCodeID="C218618">
                    <ich:ICHDefinition>Section 9.2.3.1 of the ICH M11 Protocol standard, Regulatory Reporting Requirements.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.2.3.1 Regulatory Reporting Requirements</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.2.4 Adverse Events of Special Interest" nciodm:ExtCodeID="C218619">
                    <ich:ICHDefinition>Section 9.2.4 of the ICH M11 Protocol standard, Adverse Events of Special Interest.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.2.4 Adverse Events of Special Interest</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.2.5 Disease-related Events or Outcomes Not Qualifying as AEs or SAEs" nciodm:ExtCodeID="C218620">
                    <ich:ICHDefinition>Section 9.2.5 of the ICH M11 Protocol standard, Disease-related Events or Outcomes Not Qualifying as AEs or SAEs.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.2.5 Disease-related Events or Outcomes Not Qualifying as AEs or SAEs</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.3 Pregnancy and Postpartum Information" nciodm:ExtCodeID="C218621">
                    <ich:ICHDefinition>Section 9.3 of the ICH M11 Protocol standard, Pregnancy and Postpartum Information.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.3 Pregnancy and Postpartum Information</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.3.1 Participants Who Become Pregnant During the Trial" nciodm:ExtCodeID="C218622">
                    <ich:ICHDefinition>Section 9.3.1 of the ICH M11 Protocol standard, Participants Who Become Pregnant During the Trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.3.1 Participants Who Become Pregnant During the Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.3.2 Participants Whose Partners Become Pregnant During the Trial" nciodm:ExtCodeID="C218623">
                    <ich:ICHDefinition>Section 9.3.2 of the ICH M11 Protocol standard, Participants Whose Partners Become Pregnant During the Trial.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.3.2 Participants Whose Partners Become Pregnant During the Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="9.4 Special Safety Situations" nciodm:ExtCodeID="C218624">
                    <ich:ICHDefinition>Section 9.4 of the ICH M11 Protocol standard, Special Safety Situations.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>ICH M11 Protocol Section 9.4 Special Safety Situations</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Protocol Section Name and Number Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Protocol Section Name and Number Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Protocol Section Name and Number Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217276.Reason for Amendment Response Terminology" Name="Reason for Amendment Response Terminology" DataType="text" nciodm:ExtCodeID="C217276">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the reason for amendment responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Change In Standard Of Care" nciodm:ExtCodeID="C218497">
                    <ich:ICHDefinition>A change in the standard of care necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Change in Standard Of Care Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Change In Strategy" nciodm:ExtCodeID="C218496">
                    <ich:ICHDefinition>A change in the study purpose or intent of the scientific plan necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Change in Strategy Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="IMP Addition" nciodm:ExtCodeID="C218495">
                    <ich:ICHDefinition>The addition of an investigational medicinal product to a clinical trial design necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>IMP Addition Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Inconsistency And/Or Error In The Protocol" nciodm:ExtCodeID="C218501">
                    <ich:ICHDefinition>An error or inconsistency in the protocol necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Inconsistency and/or Error in the Protocol Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigator/Site Feedback" nciodm:ExtCodeID="C218499">
                    <ich:ICHDefinition>Feedback from the investigator or study site necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigator/Site Feedback Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="IRB/IEC Feedback" nciodm:ExtCodeID="C218492">
                    <ich:ICHDefinition>Feedback from the institutional review board or independent ethics committee necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>IRB/IEC Feedback Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Manufacturing Change" nciodm:ExtCodeID="C218494">
                    <ich:ICHDefinition>A change to manufacturing processes of the study agents necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Manufacturing Change Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="New Data Available (Other Than Safety Data)" nciodm:ExtCodeID="C218498">
                    <ich:ICHDefinition>Previously unavailable data (other than safety data) becomes available, which necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>New Data Available (Other Than Safety Data) Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="New Regulatory Guidance" nciodm:ExtCodeID="C218491">
                    <ich:ICHDefinition>A regulatory agency has published a guidance document that necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>New Regulatory Guidance Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="New Safety Information Available" nciodm:ExtCodeID="C218493">
                    <ich:ICHDefinition>Previously unavailable safety data becomes available, which necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>New Safety Information Available Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Not Applicable" nciodm:ExtCodeID="C48660">
                    <ich:ICHDefinition>Determination of a value is not relevant in the current context.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Not Applicable</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Other" nciodm:ExtCodeID="C17649">
                    <ich:ICHSynonym>Other</ich:ICHSynonym>
                    <ich:ICHDefinition>Different than the one(s) previously specified or mentioned.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Other</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Protocol Design Error" nciodm:ExtCodeID="C218502">
                    <ich:ICHDefinition>A protocol design error necessitates a change(s) to, or formal clarification of, a document.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Design Error Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Recruitment Difficulty" nciodm:ExtCodeID="C218500">
                    <ich:ICHDefinition>Challenges with participant recruitment necessitates a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Recruitment Difficulty Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Regulatory Agency Request To Amend" nciodm:ExtCodeID="C218490">
                    <ich:ICHDefinition>A regulatory agency has expressed a need for a change(s) to, or formal clarification of, the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Regulatory Agency Request to Amend Amendment Reason</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Reason for Amendment Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Reason for Amendment Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Reason for Amendment Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217273.Sponsor Approval Date Response Terminology" Name="Sponsor Approval Date Response Terminology" DataType="text" nciodm:ExtCodeID="C217273">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the sponsor approval date responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Location of Sponsor Approval Date" nciodm:ExtCodeID="C218484">
                    <ich:ICHDefinition>The physical or virtual location of the date on which the sponsor approved the current version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Location of Sponsor Approval Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor Approval Date" nciodm:ExtCodeID="C132352">
                    <ich:ICHDefinition>The date that the sponsor approved the current version of the protocol.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Protocol Approval by Sponsor Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Sponsor Approval Date Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Sponsor Approval Date Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Sponsor Approval Date Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217283.Trial Arm Type Response Terminology" Name="Trial Arm Type Response Terminology" DataType="text" nciodm:ExtCodeID="C217283">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the trial arm type responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Active Comparator Arm" nciodm:ExtCodeID="C174267">
                    <ich:ICHSynonym>Active Comparator Arm</ich:ICHSynonym>
                    <ich:ICHDefinition>An arm describing the active comparator.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Active Comparator Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Control Arm" nciodm:ExtCodeID="C174226">
                    <ich:ICHDefinition>An arm describing the intervention or treatment plan for a group of participants in the study receiving a control. The control may comprise a non-investigational product (active control) or regimen, placebo, or no treatment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Control Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Experimental Arm" nciodm:ExtCodeID="C174266">
                    <ich:ICHSynonym>Investigational Arm</ich:ICHSynonym>
                    <ich:ICHSynonym>Treatment Arm</ich:ICHSynonym>
                    <ich:ICHDefinition>An arm describing the intervention or treatment plan for a group of participants in the study receiving test product(s).</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigational Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="No Intervention Arm" nciodm:ExtCodeID="C174270">
                    <ich:ICHSynonym>No Intervention Arm</ich:ICHSynonym>
                    <ich:ICHDefinition>A study arm without an intervention or treatment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>No Intervention Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Placebo Comparator Arm" nciodm:ExtCodeID="C174268">
                    <ich:ICHSynonym>Placebo Control Arm</ich:ICHSynonym>
                    <ich:ICHDefinition>An arm describing the placebo comparator.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Placebo Control Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sham Comparator Arm" nciodm:ExtCodeID="C174269">
                    <ich:ICHSynonym>Sham Intervention Arm</ich:ICHSynonym>
                    <ich:ICHDefinition>An arm describing the sham comparator.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Sham Comparator Arm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Trial Arm Type Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Trial Arm Type Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Trial Arm Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217281.Trial Blinding Role Response Terminology" Name="Trial Blinding Role Response Terminology" DataType="text" nciodm:ExtCodeID="C217281">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the trial blinding role responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Care Provider" nciodm:ExtCodeID="C17445">
                    <ich:ICHSynonym>Carer</ich:ICHSynonym>
                    <ich:ICHDefinition>The primary person in charge of the care of a patient, usually a family member or a designated health care professional.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Caregiver</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Investigator" nciodm:ExtCodeID="C25936">
                    <ich:ICHDefinition>A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at the trial site, the investigator is the responsible leader of the team and may be called the principal investigator.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Investigator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Not Applicable" nciodm:ExtCodeID="C48660">
                    <ich:ICHDefinition>Determination of a value is not relevant in the current context.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Not Applicable</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Outcomes Assessor" nciodm:ExtCodeID="C207599">
                    <ich:ICHDefinition>The individual who evaluates the outcome(s) of interest. (CDISC)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Outcomes Assessor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Participant" nciodm:ExtCodeID="C142710">
                    <ich:ICHDefinition>A member of the clinical study population from whom data are being collected. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Study Participant</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Sponsor" nciodm:ExtCodeID="C70793">
                    <ich:ICHDefinition>The literal identifier (i.e., distinctive designation) of the trial sponsor.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Clinical Study Sponsor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Trial Blinding Role Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Trial Blinding Role Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Trial Blinding Role Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217051.Trial Blinding Schema Response Terminology" Name="Trial Blinding Schema Response Terminology" DataType="text" nciodm:ExtCodeID="C217051">
                <Description>
                    <TranslatedText xml:lang="en">Terminology associated with the trial blind schema value set codelist of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Double Blind" nciodm:ExtCodeID="C15228">
                    <ich:ICHSynonym>Double Masked</ich:ICHSynonym>
                    <ich:ICHSynonym>Double-Masked</ich:ICHSynonym>
                    <ich:ICHDefinition>A study in which neither the participant nor the study personnel interacting with the participant or data during the study knows what intervention a participant is receiving.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Double Blind Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Observer Blind" nciodm:ExtCodeID="C187674">
                    <ich:ICHDefinition>A study in which the study personnel who measure, record, or assess the participant do not know which intervention the participant is receiving or, in the context of observational studies, do not know the external factors to which a participant has been exposed.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Observer Blind Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Open Label" nciodm:ExtCodeID="C49659">
                    <ich:ICHDefinition>A study in which participants and study personnel know which intervention each participant is receiving.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Open Label Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Single Blind" nciodm:ExtCodeID="C28233">
                    <ich:ICHSynonym>Single Masked</ich:ICHSynonym>
                    <ich:ICHSynonym>Single-Masked</ich:ICHSynonym>
                    <ich:ICHDefinition>A study in which one party, either the participant or study personnel, does not know which intervention is administered to the participant.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Single Blind Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Trial Blinding Schema Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Trial Blinding Schema Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Trial Blind Schema Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217280.Trial Intervention Assignment Method Response Terminology" Name="Trial Intervention Assignment Method Response Terminology" DataType="text" nciodm:ExtCodeID="C217280">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the trial intervention assignment method responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Randomisation" nciodm:ExtCodeID="C25196">
                    <ich:ICHDefinition>The process of assigning trial participants to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. (CDISC Glossary)</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Stratification" nciodm:ExtCodeID="C25689">
                    <ich:ICHDefinition>Grouping defined by important prognostic factors measured at baseline.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Stratification</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Stratified Randomisation" nciodm:ExtCodeID="C147145">
                    <ich:ICHDefinition>The process of grouping trial participants into strata according to important prognostic factors and then assigning participants within each stratum to different treatment or control groups using an element of chance and in order to reduce bias.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Stratified Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Trial Intervention Assignment Method Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Trial Intervention Assignment Method Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Trial Intervention Assignment Method Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217045.Trial Phase Response Terminology" Name="Trial Phase Response Terminology" DataType="text" nciodm:ExtCodeID="C217045">
                <Description>
                    <TranslatedText xml:lang="en">Terminology associated with the trial phase value set codelist of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Early Phase 1" nciodm:ExtCodeID="C54721">
                    <ich:ICHSynonym>Early Trial Phase 1</ich:ICHSynonym>
                    <ich:ICHDefinition>First-in-human trials, in a small number of participants, that are conducted before Phase 1 trials and are intended to assess new candidate therapeutic and imaging agents. The study agent is administered at a low dose for a limited time, and there is no therapeutic or diagnostic intent.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase 0 Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 1" nciodm:ExtCodeID="C15600">
                    <ich:ICHSynonym>1</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Phase 1</ich:ICHSynonym>
                    <ich:ICHDefinition>The initial administration of an investigational medicinal product (IMP) into humans in order to examine clinical tolerability and therapeutic intent. Phase 1 trials are typically closely monitored and may be conducted in patients or healthy volunteer participants.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase I Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 1/Phase 2" nciodm:ExtCodeID="C15693">
                    <ich:ICHSynonym>1/2</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Phase 1-2</ich:ICHSynonym>
                    <ich:ICHDefinition>A clinical trial that combines elements characteristic of traditional Phase 1 and Phase 2 trials.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase I/II Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 1/Phase 2/Phase 3" nciodm:ExtCodeID="C198366">
                    <ich:ICHSynonym>1/2/3</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Phase 1/2/3</ich:ICHSynonym>
                    <ich:ICHDefinition>A clinical trial that begins as a Phase 1 trial and transitions into Phases 2 and 3 based upon successful completion of a milestone that enables transition.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase I/II/III Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 1/Phase 3" nciodm:ExtCodeID="C198367">
                    <ich:ICHSynonym>1/3</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Phase 1/3</ich:ICHSynonym>
                    <ich:ICHDefinition>A clinical trial that begins as a Phase 1 trial and transitions into a Phase 3 trial based upon successful completion of a milestone that enables transition.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase I/III Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 2" nciodm:ExtCodeID="C15601">
                    <ich:ICHSynonym>2</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Phase 2</ich:ICHSynonym>
                    <ich:ICHDefinition>Exploratory trials conducted to evaluate the safety and efficacy of the investigational intervention in patients with the disease or condition. Objectives can be clinical pharmacology, dose-ranging (dose-response, frequency of dosing), type of patients, or numerous other characteristics of safety and efficacy.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase II Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 2/Phase 3" nciodm:ExtCodeID="C15694">
                    <ich:ICHSynonym>2/3</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Phase 2-3</ich:ICHSynonym>
                    <ich:ICHDefinition>A clinical trial that combines elements characteristic of traditional Phase 2 and Phase 3 trials.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase II/III Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 2/Phase 3/Phase 4" nciodm:ExtCodeID="C217024">
                    <ich:ICHDefinition>A clinical trial that begins as a Phase 2 trial and transitions into Phases 3 and 4 based upon successful completion of a milestone that enables transition.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase II/III/IV Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 3" nciodm:ExtCodeID="C15602">
                    <ich:ICHSynonym>3</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Phase 3</ich:ICHSynonym>
                    <ich:ICHDefinition>Confirmatory trials conducted to demonstrate safety, efficacy and tolerability of the intervention in patients with the disease or condition. Their objectives are to evaluate the overall benefit-risk relationship and to provide substantial evidence for regulatory approval and labeling.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase III Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 3/Phase 4" nciodm:ExtCodeID="C217025">
                    <ich:ICHDefinition>A clinical trial that combines elements characteristic of traditional Phase 3 and Phase 4 trials.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase III/IV Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Phase 4" nciodm:ExtCodeID="C15603">
                    <ich:ICHSynonym>4</ich:ICHSynonym>
                    <ich:ICHSynonym>Trial Phase 4</ich:ICHSynonym>
                    <ich:ICHDefinition>Post-approval trials conducted to further understand the safety and efficacy of the drug in its approved indication. They are not considered necessary for approval but are often important for optimising the drug&apos;s use.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Phase IV Trial</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Trial Phase Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Trial Phase Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Trial Phase Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217049.Trial Site Distribution Response Terminology" Name="Trial Site Distribution Response Terminology" DataType="text" nciodm:ExtCodeID="C217049">
                <Description>
                    <TranslatedText xml:lang="en">Terminology associated with the site distribution value set codelist of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Multicentre" nciodm:ExtCodeID="C217005">
                    <ich:ICHDefinition>A clinical trial conducted according to a single protocol but at more than one site, and therefore, carried out by more than one investigator.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Multicenter Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Single-Centre" nciodm:ExtCodeID="C217004">
                    <ich:ICHDefinition>A clinical trial that is conducted at a single site.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Single-Center Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Trial Site Distribution Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Trial Site Distribution Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Trial Site Distribution Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217050.Trial Site Geographic Scope Response Terminology" Name="Trial Site Geographic Scope Response Terminology" DataType="text" nciodm:ExtCodeID="C217050">
                <Description>
                    <TranslatedText xml:lang="en">Terminology associated with the site geographic scope value set codelist of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Multiple Countries" nciodm:ExtCodeID="C217007">
                    <ich:ICHDefinition>Of, or pertaining to, an occurrence in more than one country.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Multiple Countries</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Single Country" nciodm:ExtCodeID="C217006">
                    <ich:ICHDefinition>Of, or pertaining to, an occurrence in one country.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Single Country</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Trial Site Geographic Scope Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Trial Site Geographic Scope Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Trial Site Geographic Scope Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217287.Trial-Related Safety Event Type Response Terminology" Name="Trial-Related Safety Event Type Response Terminology" DataType="text" nciodm:ExtCodeID="C217287">
                <Description>
                    <TranslatedText xml:lang="en">A valid value set relevant to the trial-related safety event type responses within the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="Adverse Event" nciodm:ExtCodeID="C41331">
                    <ich:ICHSynonym>Adverse Experience</ich:ICHSynonym>
                    <ich:ICHSynonym>AE</ich:ICHSynonym>
                    <ich:ICHDefinition>Any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Adverse Event</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Lactation Event" nciodm:ExtCodeID="C218510">
                    <ich:ICHDefinition>Any event that occurs when the participant is lactating.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Lactation Event</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Medical Device Product Complaint" nciodm:ExtCodeID="C54026">
                    <ich:ICHSynonym>MD PC</ich:ICHSynonym>
                    <ich:ICHDefinition>Any concern about the safety, quality, and/or performance of a trial-related drug-device combination.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Device Problem</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Not Reportable Adverse Event of Special Interest" nciodm:ExtCodeID="C218513">
                    <ich:ICHSynonym>Not Reportable AESI</ich:ICHSynonym>
                    <ich:ICHDefinition>An adverse event of special interest (serious or non-serious) is one of scientific and medical concern specific to the sponsor&apos;s product or program, for which ongoing monitoring and rapid communication by the investigator to the sponsor could be appropriate, and which is deemed to be not reportable to the appropriate regulatory authority.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Not Reportable Adverse Event of Special Interest</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Post-Partum Event" nciodm:ExtCodeID="C218511">
                    <ich:ICHDefinition>Any event that occurs when the participant is in the stages of recovery post pregnancy and birth event.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Post-Partum Event</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Pregnancy Event" nciodm:ExtCodeID="C218509">
                    <ich:ICHDefinition>Any event that occurs when the participant or participant&apos;s partner becomes pregnant or is pregnant.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Pregnancy Event</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Reportable Adverse Event of Special Interest" nciodm:ExtCodeID="C218512">
                    <ich:ICHSynonym>Reportable AESI</ich:ICHSynonym>
                    <ich:ICHDefinition>An adverse event of special interest (serious or non-serious) is one of scientific and medical concern specific to the sponsor&apos;s product or program, for which ongoing monitoring and rapid communication by the investigator to the sponsor could be appropriate, and which is deemed to be reportable to the appropriate regulatory authority.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Reportable Adverse Event of Special Interest</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Serious Adverse Event" nciodm:ExtCodeID="C41335">
                    <ich:ICHSynonym>SAE</ich:ICHSynonym>
                    <ich:ICHDefinition>Any untoward medical occurrence that at any dose: results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or any other medically significant event that may not be immediately life-threatening or result in death or hospitalisation but may jeopardise the patient or may require intervention to prevent one of the other outcomes listed in the definition.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Serious Adverse Event</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="Trial Intervention Complaint" nciodm:ExtCodeID="C218508">
                    <ich:ICHDefinition>Any concern about the safety and/or quality of any trial-related interventions.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Trial Intervention Complaint</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Trial-Related Safety Event Type Response Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Trial-Related Safety Event Type Response Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Trial-Related Safety Event Type Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
            <CodeList OID="CL.C217048.Unit of Measure Terminology" Name="Unit of Measure Terminology" DataType="text" nciodm:ExtCodeID="C217048">
                <Description>
                    <TranslatedText xml:lang="en">Terminology associated with the units of measure value set codelist of the ICH M11 protocol template.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="DAYS" nciodm:ExtCodeID="C25301">
                    <ich:ICHDefinition>A unit of measurement of time equal to 24 hours.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Day</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="HOURS" nciodm:ExtCodeID="C25529">
                    <ich:ICHSynonym>h</ich:ICHSynonym>
                    <ich:ICHSynonym>Hours</ich:ICHSynonym>
                    <ich:ICHSynonym>hr</ich:ICHSynonym>
                    <ich:ICHDefinition>A unit of measurement of time equal to 60 minutes.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Hour</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="MONTHS" nciodm:ExtCodeID="C29846">
                    <ich:ICHSynonym>Month</ich:ICHSynonym>
                    <ich:ICHDefinition>One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon&apos;s phases, about 30 days or 4 weeks.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Month</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="WEEKS" nciodm:ExtCodeID="C29844">
                    <ich:ICHSynonym>Week</ich:ICHSynonym>
                    <ich:ICHDefinition>Any period of seven consecutive days.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Week</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="YEARS" nciodm:ExtCodeID="C29848">
                    <ich:ICHSynonym>Year</ich:ICHSynonym>
                    <ich:ICHDefinition>The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.</ich:ICHDefinition>
                    <nciodm:PreferredTerm>Year</nciodm:PreferredTerm>
                </EnumeratedItem>
                <ich:ICHSubmissionValue>Unit of Measure Terminology</ich:ICHSubmissionValue>
                <ich:ICHSynonym>Unit of Measure Terminology</ich:ICHSynonym>
                <nciodm:PreferredTerm>ICH M11 Units of Measure Value Set Terminology</nciodm:PreferredTerm>
            </CodeList>
        </MetaDataVersion>
    </Study>
</ODM>
